0000000000465398

AUTHOR

Klaus Lieb

showing 108 related works from this author

Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systemati…

2017

Early improvement of depressive symptoms during the first two weeks of antidepressant treatment has been discussed to be a resilience signal predicting a later positive treatment outcome in patients with Major Depressive Disorder (MDD). However, the predictive value of early improvement varies between studies, and the use of different antidepressants may explain heterogeneous results. The objective of this review was to assess the predictive value of early improvement on later response and remission and to identify antidepressants with the highest chance of early improvement. We included 17 randomized controlled trials investigating early improvement in 14,779 adult patients with MDD compar…

medicine.medical_specialtymedicine.drug_classmedia_common.quotation_subjectMirtazapineTricyclic antidepressantPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineOutcome Assessment Health CaremedicineHumansPsychiatryBiological Psychiatrymedia_commonDepressive Disorder MajorResilience Psychologicalmedicine.diseaseAntidepressive Agents030227 psychiatryPsychiatry and Mental healthMeta-analysisAntidepressantMajor depressive disorderPsychological resiliencePsychology030217 neurology & neurosurgerymedicine.drugJournal of psychiatric research
researchProduct

Widerstandskraft im Alter: Mit Resilienz gesund alt werden

2019

Resilienz als psychologisches Konzept ist die seelische Widerstandskraft zur Aufrechterhaltung oder Ruckgewinnung der psychischen Gesundheit wahrend oder nach widrigen Lebensumstanden. In der Resilienzforschung konzentrierte man sich lange auf die Erforschung der Entstehung und Behandlung von bereits vorliegenden Erkrankungen. Mit der Deklaration „Health for all“ (1978) der Weltgesundheitsorganisation und Antonovskys Konzept der Salutogenese (1979) vollzog sich ein grundlegender Perspektivenwechsel. Nicht nur die Frage, was den Menschen krank macht (Pathogenese), sondern insbesondere die Frage, was gesund halt (Salutogense) steht heute im Mittelpunkt der Arbeit. Die Resilienzforschung ist d…

researchProduct

S08-01 - Cochrane Reviews of Pharmacological and Psychological Interventions for Antisocial Personality Disorder (ASPD)

2010

IntroductionASPD has a prevalence of 2-3% in the general population but rates in prison have been reported as 50% to 75%. ASPD is associated with significant psychiatric and medical comorbidity, high offending rates, poor psychosocial adaptation and premature death. Outcomes are poor. There is little consensus regarding the most effective intervention for the condition.Aims and objectivesTo conduct systematic literature reviews to identify randomised controlled trials for either pharmacological or psychological interventions for ASPD.MethodsSystematic literature reviews (Cochrane reviews).ResultsFor the review on psychological interventions only 11 studies could be included with a total of …

education.field_of_studymedicine.medical_specialtyAggressionmedia_common.quotation_subjectAntisocial personality disorderPopulationPsychological interventionContingency managementPrisonmedicine.diseasePsychiatry and Mental healthIntervention (counseling)mental disordersmedicinemedicine.symptomeducationPsychiatryPsychologyPsychosocialClinical psychologymedia_commonEuropean Psychiatry
researchProduct

Pharmacological interventions for paranoid personality disorder

2014

Reason for withdrawal from publication Authors have made no progress with this protocol in over three years due to difficulties with identifying potentially suitable studies. The protocol has been withdrawn. To view the published versions of this article, please click the 'Other versions' tab.

Protocol (science)medicine.medical_specialtyPsychotherapistgenetic structuresbusiness.industryComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKSMEDLINEAlternative medicinemedicine.diseaseArticlePharmacological interventionsParanoid personality disordermedicinebusiness
researchProduct

Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial.

2017

Stimulants and caffeine have been proposed for cognitive enhancement by healthy subjects. This study investigated whether performance in chess - a competitive mind game requiring highly complex cognitive skills - can be enhanced by methylphenidate, modafinil or caffeine. In a phase IV, randomized, double-blind, placebo-controlled trial, 39 male chess players received 2×200mg modafinil, 2×20mg methylphenidate, and 2×200mg caffeine or placebo in a 4×4 crossover design. They played twenty 15-minute games during two sessions against a chess program (Fritz 12; adapted to players' strength) and completed several neuropsychological tests. Marked substance effects were observed since all three subs…

AdultMaleElementary cognitive taskmedicine.medical_specialtyModafinilAudiologyNeuropsychological TestsPlacebolaw.inventionDevelopmental psychology03 medical and health sciences0302 clinical medicineCognitionRandomized controlled trialDouble-Blind MethodlawCaffeinemedicineHumansPharmacology (medical)Benzhydryl CompoundsBiological PsychiatryRetrospective StudiesPharmacologyAnalysis of VarianceMethylphenidateModafinilNeuropsychologyCognitionWakefulness-Promoting AgentsMiddle AgedCrossover study030227 psychiatryPsychiatry and Mental healthCross-Sectional StudiesNeurologyMethylphenidateCentral Nervous System StimulantsFemaleNeurology (clinical)Psychologyhuman activities030217 neurology & neurosurgerymedicine.drugEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

Short-term Psychological Interventions for Bordeline Personality Disorder–What Works?

2017

IntroductionBorderline personality disorder (BPD) is a common and disabling personality disorder associated with difficulties in controlling emotions and impulses, self-injury, feelings of emptiness and abandonment. It is associated with problems in many areas of life, most notably relationships. Psychotherapy is the first-line treatment for people with borderline personality disorder widely used; however, the evidence is not thoroughly investigated. In addition, several specific short-term interventions have been developed during the last decades.ObjectivesWe are currently updating this cochrane collaboration review on psychological interventions for BPD. First findings on the up-to-date e…

medicine.medical_specialtymedia_common.quotation_subjectPsychological interventionmedicine.diseasePersonality disorderslaw.inventionPsychiatry and Mental healthFeelingRandomized controlled triallawmedicineAbandonment (emotional)AnxietyPersonalitymedicine.symptomPsychiatryPsychologyBorderline personality disordermedia_commonClinical psychologyEuropean Psychiatry
researchProduct

Muster des Missbrauchs von (Psycho-) Stimulanzien zum pharmakologischen Neuroenhancement bei Studierenden

2011

Auch in Deutschland werden verschreibungspflichtige und illegale (Psycho-) Stimulanzien wie Methylphenidat und Amphetamine von Studierenden ohne medizinische Indikation zur geistigen Leistungssteigerung missbraucht. Uber die Charakteristika dieses sog. pharmakologischen Neuroenhancements (PN) ist bislang nur wenig bekannt. Semistrukturierte Interviews mit 20 Studierenden, die Stimulanzien zum PN eingenommen haben, uber Aspekte des PN (Motive, Einstellungen usw.). Es lassen sich 2 Muster des Substanzmissbrauchs zum PN unterscheiden, die zum Teil fliesend ineinander ubergehen und die exemplarisch anhand zweier Fallbeispiele dargestellt werden: Ein Muster ist charakterisiert durch transienten …

GynecologyPsychiatry and Mental healthmedicine.medical_specialtyPolitical sciencemedicineApplied PsychologySuchttherapie
researchProduct

Increased CSF APPs-  levels in patients with Alzheimer disease treated with acitretin

2014

Objective: We investigated induction of α-secretase A disintegrin and metalloprotease 10 (ADAM10) by the synthetic retinoid acitretin (Neotigason; Actavis, Munchen-Riem, Germany) in patients with mild to moderate Alzheimer disease (AD) via measurement of CSF content of α-secretase–derived amyloid precursor protein (APPs-α). Methods: Twenty-one patients clinically diagnosed with mild to moderate AD received acitretin (30 mg per day) or placebo in a 4-week double-blind study. Primary endpoint was the difference of CSF APPs-α ratios calculated from the APPs-α levels after treatment and at baseline. We monitored safety and tolerability of the treatment. In addition, we assessed biomarkers such …

MaleDrugmedicine.medical_specialtymedia_common.quotation_subjectPilot ProjectsPlaceboGastroenterologyAcitretinlaw.inventionDouble-Blind MethodRandomized controlled trialAlzheimer Diseasecerebrospinal fluid [Amyloid Precursor Protein Secretases]lawInternal medicinemedicineClinical endpointdrug therapy [Alzheimer Disease]Humansddc:610Prospective StudiesProspective cohort studyAgedmedia_commonbusiness.industrytherapeutic use [Acitretin]diagnosis [Alzheimer Disease]Middle Agedmedicine.diseaseAcitretincerebrospinal fluid [Alzheimer Disease]Treatment Outcomecerebrospinal fluid [Biomarkers]TolerabilityFemaleNeurology (clinical)Amyloid Precursor Protein SecretasesAlzheimer's diseasebusinessBiomarkersmedicine.drugNeurology
researchProduct

Neural correlates of antinociception in borderline personality disorder.

2006

Context A characteristic feature of borderline personality disorder (BPD) is self-injurious behavior in conjunction with stress-induced reduction of pain perception. Reduced pain sensitivity has been experimentally confirmed in patients with BPD, but the neural correlates of antinociceptive mechanisms in BPD are unknown. We predicted that heat stimuli in patients with BPD would activate brain areas concerned with cognitive and emotional evaluation of pain. Objective To assess the psychophysical properties and neural correlates of altered pain processing in patients with BPD. Design Case-control study. Setting A university hospital. Participants Twelve women with BPD and self-injurious behav…

AdultPain Thresholdmedicine.medical_specialtyHot TemperatureDifferential ThresholdPainPrefrontal CortexAudiologybehavioral disciplines and activitiesAmygdalaGyrus CingulimethodsArts and Humanities (miscellaneous)bloodBorderline Personality DisorderPhysical StimulationAdult Amygdala; physiopathology Borderline Personality Disorder; diagnosis/physiopathology/psychology Brain Mapping Brain; physiopathology Case-Control Studies Differential Threshold; physiology Female Gyrus Cinguli; physiopathology Hot Temperature; diagnostic use Humans Magnetic Resonance Imaging Oxygen; blood Pain Measurement; methods Pain Threshold; physiology Pain; diagnosis/physiopathology/psychology Physical Stimulation Prefrontal Cortex; physiopathology Self-Injurious Behavior; diagnosis/physiopathology Thermosensing; physiologymental disordersThreshold of painmedicineHumansThermosensingPrefrontal cortexPsychiatryBorderline personality disorderPain MeasurementBrain MappingBlood-oxygen-level dependentmedicine.diagnostic_testBrainmedicine.diseaseAmygdalaMagnetic Resonance Imagingdiagnosis/physiopathologyFunctional imagingDorsolateral prefrontal cortexOxygenPsychiatry and Mental healthmedicine.anatomical_structureCase-Control StudiesphysiologyFemalediagnosis/physiopathology/psychologyphysiopathologydiagnostic useFunctional magnetic resonance imagingPsychologySelf-Injurious BehaviorArchives of general psychiatry
researchProduct

Psychological interventions for obsessive-compulsive personality disorder

2010

Reason for withdrawal from publication Authors have made no progress with this protocol in over three years due to difficulties with identifying potentially suitable studies. The protocol has been withdrawn. To view the published versions of this article, please click the 'Other versions' tab.

Protocol (science)medicine.medical_specialtyPsychotherapistgenetic structuresbusiness.industryComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKSAlternative medicinePsychological interventionMEDLINEmedicine.diseaseArticleObsessive–compulsive personality disordermedicinebusiness
researchProduct

Corrigendum to "Intervention studies to foster resilience - A systematic review and proposal for a resilience framework in future intervention studie…

2018

060201 languages & linguisticsPsychiatry and Mental healthClinical PsychologyPsychotherapist0602 languages and literature05 social sciencesMEDLINE050301 education06 humanities and the artsResilience (network)Psychology0503 educationIntervention studiesClinical psychology review
researchProduct

Charakteristika von Studierenden, die pharmakologisches Neuroenhancement mit Stimulanzien betreiben: Eine Pilotstudie

2012

Anliegen: Charakterisierung deutscher Studenten, die Methylphenidat (MPH) und/oder Amphetamine (AMPH) zum pharmakologischen Neuroenhancement (PN) konsumieren. Methode: Semistrukturierte Interviews mit 20 Konsumenten und 20 Kontrollprobanden. Ergebnisse: Die Konsumenten waren besser uber die Moglichkeit der Einnahme illegaler Substanzen zum PN informiert als die Kontrollgruppe. AMPH-Konsumenten nahmen haufiger weitere illegale Substanzen zum PN ein als MPH-Konsumenten, wahrend hinsichtlich legaler Substanzen zum PN kein Unterschied zwischen den beiden Konsumentengruppen bestand. AMPH-Konsumenten hatten AMPH vornehmlich nasal eingenommen. Insgesamt wiesen die Stimulanzienkonsumenten haufiger …

GynecologyPsychiatry and Mental healthmedicine.medical_specialtybusiness.industrymedicinebusinessPsychiatrische Praxis
researchProduct

Early onset of depression and treatment outcome in patients with major depressive disorder

2021

Major depressive disorder (MDD) is a highly heterogeneous disorder, which may partly explain why treatment outcome using antidepressants is unsatisfactory. We investigated the onset of depression as a possible clinical marker for therapy response prediction in the context of somatic biomarkers blood pressure and plasma electrolyte concentration. 889 MDD patients were divided into early (EO, n = 226), intermediate (IO, n = 493), and late onset (LO, n = 169) patients and were analyzed for differences in socio-demographic and clinical parameters, comorbidities and treatment outcome as well as systolic blood pressure and electrolytes. EO patients more often suffered from a recurrent depression,…

medicine.medical_specialtyTreatment outcomeLate onsetContext (language use)03 medical and health sciences0302 clinical medicineInternal medicineHumansMedicineIn patientAge of OnsetBiological PsychiatryDepression (differential diagnoses)Early onsetDepressive Disorder MajorDepressionbusiness.industrymedicine.diseaseAntidepressive Agents030227 psychiatryPsychiatry and Mental healthTreatment OutcomeBlood pressureMajor depressive disorderbusiness030217 neurology & neurosurgeryJournal of Psychiatric Research
researchProduct

Corrigendum to ‘State dependent posterior hippocampal volume increases in patients with major depressive disorder’ [J. Affect. Disord. 135 (1–3) (201…

2016

medicine.medical_specialtybusiness.industrymedicine.diseaseAffect (psychology)Psychiatry and Mental healthClinical PsychologyEndocrinologyState dependentInternal medicineAnesthesiamedicineHippocampal volumeMajor depressive disorderIn patientbusinessJournal of Affective Disorders
researchProduct

Differential effects of age on subcomponents of response inhibition.

2013

Inhibitory deficits contribute to cognitive decline in the aging brain. Separating subcomponents of response inhibition may help to resolve contradictions in the existing literature. A total of 49 healthy participants underwent functional magnetic resonance imaging (fMRI) while performing a Go/no-go-, a Simon-, and a Stop-signal task. Regression analyses were conducted to identify correlations of age and activation patterns. Imaging results revealed a differential effect of age on subcomponents of response inhibition. In a simple Go/no-go task (no spatial discrimination), aging was associated with increased activation of the core inhibitory network and parietal areas. In the Simon task, whi…

AdultMaleAgingSpatial discriminationNeuropsychological TestsInhibitory postsynaptic potentialDevelopmental psychologyTask (project management)Young AdultmedicineReaction TimeAging brainHumansCognitive declineResponse inhibitionAgedmedicine.diagnostic_testGeneral NeuroscienceBrainMiddle AgedDifferential effectsMagnetic Resonance ImagingInhibition PsychologicalNeurology (clinical)Geriatrics and GerontologyFunctional magnetic resonance imagingPsychologyCognition DisordersNeuroscienceDevelopmental BiologyNeurobiology of aging
researchProduct

Declaration and Handling of Conflicts of Interest in Guidelines

2015

Clinical guidelines are developed in order to support physicians and patients in specific clinical situations when decisions concerning diagnosis and treatment are made. Recommendations provided in guidelines are based on the findings of clinical studies and on expert opinion. Identical study findings may be evaluated differently depending on whether or not guideline authors have conflicts of interest (1). A conflict of interest is defined as a circumstance that gives rise to a risk that professional judgement or actions concerning a primary interest may be inappropriately influenced by a secondary interest (2, 3). A conflict of interest is therefore a state of affairs, not a biased evaluat…

business.industryDownloadmedia_common.quotation_subjectDeclarationConflict of interestGeneral MedicineGuidelinePublic relationsSchool of thoughtScientific evidenceConvictionMedicinebusinessDutymedia_commonDeutsches Ärzteblatt international
researchProduct

Is pharmacotherapy useful for treating personality disorders?

2021

Personality disorders are characterized by enduring maladaptive patterns of behavior, cognition, and inner experience exhibited across many contexts and deviating from those accepted by the individ...

Pharmacologybusiness.industryAntisocial personality disorderMEDLINECognitionGeneral Medicinemedicine.diseaseSchizotypal personality disorderPersonality disordersPersonality Disorders03 medical and health sciencesDrug treatment0302 clinical medicinePharmacotherapyBorderline Personality Disorder030220 oncology & carcinogenesismedicineHumansPharmacology (medical)businessBorderline personality disorder030217 neurology & neurosurgeryClinical psychologyExpert opinion on pharmacotherapy
researchProduct

Differential associations of leisure music engagement with resilience : A network analysis

2023

Background/Objective Several factors associated with resilience as the maintenance of mental health despite stress exposure can be strengthened through participation in leisure time activities. Since many people listen to or make music in their leisure time, the aim of the present study was to provide insights into the architecture of how resilience relates to passive and active music engagement. Method 511 participants regularly listening to and/or making music completed an online survey on resilient outcomes (i.e., mental health and stressor recovery ability), different resilience factors (e.g., optimism, social support), quantitative music engagement (i.e., time spent with music listenin…

resilienssimielialamusiikkieveryday lifemusiikkipsykologiastressiarkielämäClinical Psychologystressmielenterveysmusiikin harrastaminenmood regulationmusic listeningmental healthmusic making
researchProduct

The frequent stressor and mental health monitoring-paradigm: a proposal for the operationalization and measurement of resilience and the identificati…

2021

Resilience has been defined as the maintenance or quick recovery of mental health during and after times of adversity. How to operationalize resilience and to determine the factors and processes that lead to good long-term mental health outcomes in stressor-exposed individuals is a matter of ongoing debate and of critical importance for the advancement of the field. One of the biggest challenges for implementing an outcome-based definition of resilience in longitudinal observational study designs lies in the fact that real-life adversity is usually unpredictable and that its substantial qualitative as well as temporal variability between subjects often precludes defining circumscribed time …

Coping (psychology)OperationalizationStressorAllostasisadaptationMental healthDevelopmental psychologyBF1-990copingstressddc:150homeostasisdynamic systemConceptual AnalysisNormativePsychologyObservational studyallostasisddc:610Resilience (network)Psychologyhomeostasis ; dynamic system ; mental health ; adversity ; coping ; adaptation ; stress ; allostasisGeneral Psychologymental healthadversity
researchProduct

Impact of physicians’ participation in non-interventional post-marketing studies on their prescription habits: A retrospective 2-armed cohort study i…

2020

Background Non-interventional post-marketing studies (NIPMSs) sponsored by pharmaceutical companies are controversial because, while they are theoretically useful instruments for pharmacovigilance, some authors have hypothesized that they are merely marketing instruments used to influence physicians’ prescription behavior. So far, it has not been shown, to our knowledge, whether NIPMSs actually do have an influence on prescription behavior. The objective of this study was therefore to investigate whether physicians’ participation in NIPMSs initiated by pharmaceutical companies has an impact on their prescription behavior. In addition, we wanted to analyze whether specific characteristics of…

Medical DoctorsEconomicsHealth Care ProvidersSocial Sciences030204 cardiovascular system & hematologyDirected Acyclic GraphsHabits0302 clinical medicineSociologyGermanyMedicine and Health SciencesPsychologyMedicineMedical Personnel030212 general & internal medicinePractice Patterns Physicians'Marketingmedia_commonMarketingDirected GraphsRGeneral MedicineDrug MarketingProfessionsData AcquisitionResearch DesignPhysical SciencesMedicineResearch ArticleCohort studyDrugComputer and Information SciencesDrug Research and DevelopmentClinical Research Designmedia_common.quotation_subjectMEDLINEResearch and Analysis Methods03 medical and health sciencesHealth EconomicsPhysiciansPharmacovigilanceProduct Surveillance PostmarketingHumansMedical prescriptionAdverse effectRetrospective StudiesPharmacologyBehaviorbusiness.industryBiology and Life SciencesRetrospective cohort studyOdds ratioCommunicationsHealth CareGraph TheoryPeople and PlacesPopulation GroupingsAdverse EventsbusinessMathematicsHealth InsurancePLOS Medicine
researchProduct

Data-driven analysis of simultaneous EEG/fMRI reveals neurophysiological phenotypes of impulse control

2016

Response inhibition is the ability to suppress inadequate but prepotent or ongoing response tendencies. A fronto-striatal network is involved in these processes. Between-subject differences in the intra-individual variability have been suggested to constitute a key to pathological processes underlying impulse control disorders. Single-trial EEG/fMRI analysis allows to increase sensitivity for inter-individual differences by incorporating intra-individual variability. Thirty-eight healthy subjects performed a visual Go/Nogo task during simultaneous EEG/fMRI. Of 38 healthy subjects, 21 subjects reliably showed Nogo-related ICs (Nogo-IC-positive) while 17 subjects (Nogo-IC-negative) did not. C…

ElectroencephalographyInhibitory postsynaptic potentialEEG-fMRI050105 experimental psychologyDevelopmental psychology03 medical and health sciences0302 clinical medicinemental disordersmedicine0501 psychology and cognitive sciencesRadiology Nuclear Medicine and imagingPathologicalRadiological and Ultrasound Technologymedicine.diagnostic_test05 social sciencesNeurophysiologyImpulse controlElectrophysiologyNeurologyNeurology (clinical)AnatomyPsychologyNeuroscienceInsulapsychological phenomena and processes030217 neurology & neurosurgeryHuman Brain Mapping
researchProduct

Differential impact of COVID-related lockdown on mental health in Germany.

2021

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEMental healthPsychiatry and Mental healthmedicinePhychiatric Mental HealthPshychiatric Mental HealthPsychiatrybusinessLetters to the EditorDifferential impactWorld psychiatry : official journal of the World Psychiatric Association (WPA)
researchProduct

Einstellungen und Erwartungen von Patienten in Bezug auf Interessenkonflikte ihrer behandelnden Ärzte

2016

Zusammenfassung Hintergrund Patienten durfen zu Recht erwarten, dass im Vertrauensverhaltnis zu ihrem Arzt sekundare Interessen keine unangemessene Rolle spielen. Was Patienten uber Interessenkonflikte ihrer Arzte durch die Zusammenarbeit mit pharmazeutischen Unternehmern wissen und ob und wie sie daruber informiert werden wollen, ist in Deutschland wenig bekannt. Methode 765 Patienten in verschiedenen Arztpraxen und Kliniken (Ambulanzen und Stationen) zweier deutscher Stadte erhielten ein Informationsblatt zu Interessenkonflikten und einen Fragebogen mit 19 Fragen. 80% (n = 612) der Fragebogen wurden anonym ausgefullt abgegeben. Ergebnisse 65% der Patienten waren keine moglichen Interessen…

Gynecology03 medical and health sciencesmedicine.medical_specialty0302 clinical medicineHealth PolicyPolitical science010102 general mathematicsmedicineMedicine (miscellaneous)030212 general & internal medicine0101 mathematics01 natural sciencesEducationZeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen
researchProduct

Effects of age on depressive symptomatology and response to antidepressant treatment in patients with major depressive disorder aged 18 to 65 years

2020

Background: There is evidence that symptomatology in patients with major depressive disorder (MDD) changes with age. However, studies comparing depressive symptomatology between different age groups during antidepressant therapy are rare. We compared demographic and clinical characteristics in depressed patients of different age groups at baseline and during treatment. Methods: 889 MDD inpatients were divided into four age groups (18–29, 30–39, 40–49, 50–65 yrs.). Demographic and clinical characteristics including depressive symptomatology (assessed by the Inventory of Depressive Symptoms) were assessed at baseline and weekly during treatment. Results: At baseline, young patients (18–29 yea…

AdultMalePediatricsmedicine.medical_specialtyAdolescentlcsh:RC435-571IrritabilityDepressive symptomatology03 medical and health sciencesYoung Adult0302 clinical medicinelcsh:PsychiatrymedicineHumansIn patientDepression (differential diagnoses)AgedDepressive Disorder Majorbusiness.industryDepressionAge FactorsMiddle Agedmedicine.diseasePersonality disordersAntidepressive AgentsIrritable MoodSelf Concept030227 psychiatrySubstance abusePsychiatry and Mental healthClinical PsychologyTreatment OutcomeAntidepressantMajor depressive disorderFemalemedicine.symptombusiness030217 neurology & neurosurgeryComprehensive Psychiatry
researchProduct

Neural Architecture of Selective Stopping Strategies: Distinct Brain Activity Patterns Are Associated with Attentional Capture But Not with Outright …

2017

In stimulus-selective stop-signal tasks, the salient stop signal needs attentional processing before genuine response inhibition is completed. Differential prefrontal involvement in attentional capture and response inhibition has been linked to the right inferior frontal junction (IFJ) and ventrolateral prefrontal cortex (VLPFC), respectively. Recently, it has been suggested that stimulus-selective stopping may be accomplished by the following different strategies: individuals may selectively inhibit their response only upon detecting a stop signal (independent discriminate then stop strategy) or unselectively whenever detecting a stop or attentional capture signal (stop then discriminate s…

AdultMaleVentrolateral prefrontal cortexBrain activity and meditationInferior frontal gyrusCognitive neuroscienceStop signal050105 experimental psychologyDevelopmental psychologyExecutive FunctionRandom AllocationYoung Adult03 medical and health sciences0302 clinical medicineReaction TimemedicineHumansAttention0501 psychology and cognitive sciencesResearch ArticlesBrain Mappingmedicine.diagnostic_testGeneral Neuroscience05 social sciencesBrainCognitionMiddle AgedExecutive functionsInhibition Psychologicalmedicine.anatomical_structureFemaleNerve NetFunctional magnetic resonance imagingPsychologyNeurosciencePsychomotor Performance030217 neurology & neurosurgeryThe Journal of Neuroscience
researchProduct

WITHDRAWN: Association analysis between the early change of serum brain-derived neurotrophic factor (sBDNF) and final change of depression severity d…

2010

This article has been withdrawn at the request of the Editor-in-Chief. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

PharmacologyBrain-derived neurotrophic factormedicine.medical_specialtyPsychiatry and Mental healthNeurologymedicineAntidepressantPharmacology (medical)Neurology (clinical)PsychiatryPsychologyBiological PsychiatryDepression (differential diagnoses)Clinical psychologyGenetic associationEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

Von der symptomatischen zur kausalen Therapie?

2009

Until today the pharmacological therapy of Alzheimer’s disease (AD) is still limited to symptomatic temporary improvement or stabilization of cognitive performance and activities of daily living, and the reduction of neuropsychiatric symptoms of the disease. Available symptomatic treatment options are the acetylcholinesterase inhibitors (ACh-I) donepezil, galantamine, rivastigmine, and the partial N-Methyl-D-Aspartat-(NMDA)-antagonist memantine. Further substances with symptomatic targets, especially selective acetylcholine and histamine receptors, are currently under development. Numerous of disease-modifying substances mainly targeting components of the amyloidogenic pathway of AD are pre…

Rivastigminebusiness.industryMemantineDiseaseBioinformaticsAcetylcholinesteraseClinical trialPsychiatry and Mental healthchemistry.chemical_compoundPharmacotherapyNeurologychemistryGalantamineMedicineNeurology (clinical)businessDonepezilNeurosciencemedicine.drugFortschritte der Neurologie · Psychiatrie
researchProduct

Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression – The EMC trial

2015

Patients with Major Depressive Disorder (MDD) and no improvement after two weeks of antidepressant pharmacotherapy have a high risk of treatment failure. The aim of the study was to determine whether an early medication change (EMC) strategy is superior to a guideline-based treatment in MDD patients without improvement after two weeks of antidepressant pharmacotherapy. Eight-hundred-and-eighty-nine patients with MDD were enrolled, 879 patients received the SSRI escitalopram. Of those, 192 patients had no improvement, defined as a reduction of < 20% on the Hamilton Depression Rating Scale (HAMD-17) after 14 days of treatment, and were randomly assigned to open treatment with the EMC strategy…

AdultMalemedicine.medical_specialtyAdolescentCitalopramLithiumCitalopramlaw.inventionDepressive Disorder Treatment-ResistantYoung Adult03 medical and health sciences0302 clinical medicinePharmacotherapyRandomized controlled triallawEarly Medical InterventionInternal medicinemedicineHumansEscitalopramPharmacology (medical)PsychiatryBiological PsychiatryAgedPharmacologyVenlafaxine HydrochlorideGuidelineMiddle Agedmedicine.diseaseAntidepressive Agents030227 psychiatryClinical trialPsychiatry and Mental healthTreatment OutcomeNeurologyDelayed-Action PreparationsAntidepressive Agents Second-GenerationAntidepressantMajor depressive disorderDrug Therapy CombinationFemaleNeurology (clinical)Psychology030217 neurology & neurosurgerymedicine.drugEuropean Neuropsychopharmacology
researchProduct

Life context of pharmacological academic performance enhancement among university students – a qualitative approach

2014

Background Academic performance enhancement or cognitive enhancement (CE) via stimulant drug use has received increasing attention. The question remains, however, whether CE solely represents the use of drugs for achieving better academic or workplace results or whether CE also serves various other purposes. The aim of this study was to put the phenomenon of pharmacological academic performance enhancement via prescription and illicit (psycho-) stimulant use (Amphetamines, Methylphenidate) among university students into a broader context. Specifically, we wanted to further understand students’ experiences, the effects of use on students and other factors, such as pressure to perform in thei…

AdultMaleUniversitiesSubstance-Related Disorders610 MedizinStimulantsHealth(social science)Cognition610 Medical sciencesHumansStudentsNootropic AgentsQualitative ResearchLife impactEthicsMotivationHealth PolicyAmphetaminesUniversity studentsIssues ethics and legal aspectsAttitudesAcademic performance enhancementMethylphenidateEducational StatusCentral Nervous System StimulantsFemaleResearch ArticleCognitive enhancementBMC Medical Ethics
researchProduct

W05-01 - Rationale and Design of an RCT Comparing “EMC-Strategy” with TAU in Patients with Major Depression - the EMC Trial

2010

IntroductionFor Major Depression, current guidelines recommend treatment durations of 3-8 weeks until optimisation in case of insufficient outcome. Many retrospective studies indicate that improvement (HAMD-17 decrease ≥20%) occurs usually within 10-14 days and that non-improvement after 14 days of treatment is highly predictive for poor clinical outcome.MethodsIn level 1 of the EMC trial, non-improvers after 14 days of antidepressant treatment will be randomised to “early medication change” (EMC) strategy or treatment according to current guidelines (TAU). EMC schedules treatment optimisations on day 15 and day 29 in case of non-improvement. TAU schedules a medication change after 28 days …

medicine.medical_specialtyPediatricsbusiness.industryRetrospective cohort studylaw.inventionMedication changeClinical PracticePsychiatry and Mental healthRandomized controlled triallawMedicineIn patientbusinessPsychiatryDepression (differential diagnoses)European Psychiatry
researchProduct

Modulatory role of the brain-derived neurotrophic factor Val66Met polymorphism on the effects of serious life events on impulsive aggression in borde…

2009

Impulsive aggression belongs to the key features of borderline personality disorder (BPD). In the development of BPD, serious life events are known to play a major role. Acute and chronic stress has been suggested to inhibit hippocampal brain-derived neurotrophic factor (BDNF) synthesis and to mediate neural plasticity in response to adverse social experiences. Recently it has been reported that the frequency of violent suicide attempts is higher in adult suicide attempters reporting severe childhood sexual abuse and carrying the Val(66)Val genotype of the BDNF Val(66)Met polymorphism. In this study we analysed modulating effects of BDNF Val(66)Met polymorphism on the effects of physical ma…

AdultMalemedicine.medical_specialtyHeterozygoteGenotypePoison controlSuicide preventionBehavioral NeuroscienceMethionineBorderline Personality Disordermental disordersInjury preventionNeuroplasticityGeneticsmedicineHumansChronic stressPsychiatryChildBorderline personality disorderBrain-derived neurotrophic factorPolymorphism GeneticBrain-Derived Neurotrophic FactorValineChild Abuse Sexualmedicine.diseaseAggressionNeurologySexual abuseImpulsive BehaviorFemalePsychologyClinical psychologyGenes, brain, and behavior
researchProduct

Right inferior frontal gyrus implements motor inhibitory control via beta-band oscillations in humans

2021

Motor inhibitory control implemented as response inhibition is an essential cognitive function required to dynamically adapt to rapidly changing environments. Despite over a decade of research on the neural mechanisms of response inhibition, it remains unclear, how exactly response inhibition is initiated and implemented. Using a multimodal MEG/fMRI approach in 59 subjects, our results reliably reveal that response inhibition is initiated by the right inferior frontal gyrus (rIFG) as a form of attention-independent top-down control that involves the modulation of beta-band activity. Furthermore, stopping performance was predicted by beta-band power, and beta-band connectivity was directed f…

0301 basic medicineAdultMaleRight inferior frontal gyrusComputer scienceQH301-705.5ScienceBiophysicsPrefrontal Cortexstop signal taskGeneral Biochemistry Genetics and Molecular Biologypre-supplementary motor areastopping03 medical and health sciencesBeta band0302 clinical medicineCognitionInhibitory controlReaction TimeHumansresponse inhibitionBiology (General)Response inhibitionMotor areaGeneral Immunology and MicrobiologyOscillationGeneral NeuroscienceQMotor CortexRMagnetoencephalographyCognitionGeneral MedicineMagnetic Resonance ImagingattentionInhibition Psychological030104 developmental biologyMedicineFemaleBeta RhythmNeuroscience030217 neurology & neurosurgeryPsychomotor PerformanceResearch ArticleNeuroscienceHumaneLife
researchProduct

Individual participant data systematic reviews with meta-analyses of psychotherapies for borderline personality disorder

2021

IntroductionThe heterogeneity in people with borderline personality disorder (BPD) and the range of specialised psychotherapies means that people with certain BPD characteristics might benefit more or less from different types of psychotherapy. Identifying moderating characteristics of individuals is a key to refine and tailor standard treatments so they match the specificities of the individual participant. The objective of this is to improve the quality of care and the individual outcomes. We will do so by performing three systematic reviews with meta-analyses of individual participant data (IPD). The aim of these reviews is to investigate potential predictors and moderating patient chara…

SDG 16 - PeaceOutcome (game theory)03 medical and health sciences0302 clinical medicineMeta-Analysis as TopicBorderline Personality DisorderCovariatemedicineHumanspersonality disorders1506030212 general & internal medicineBorderline personality disorderMultinomial logistic regressionbusiness.industryData CollectionSDG 16 - Peace Justice and Strong InstitutionsRGeneral Medicinemedicine.disease/dk/atira/pure/sustainabledevelopmentgoals/peace_justice_and_strong_institutionsMental healthPersonality disordersJustice and Strong Institutions030227 psychiatryPsychotherapyMental HealthTreatment OutcomeSystematic reviewResearch DesignPublishingMedicine1712adult psychiatrybusinessmental healthSystematic Reviews as TopicClinical psychology
researchProduct

P01-92 - Early Changes are Associated with late Changes of BDNF Serum Levels in Inpatients with Major Depression During Short-term Antidepressant Tre…

2010

ObjectivesMean BDNF serum concentration is lower in patients with major depression (MD) as compared to healthy controls. BDNF increases during the course of antidepressant treatment. This increase has been associated with symptom amelioration. The aim of this study was to analyse the relation between early and late BDNF changes during antidepressant treatment.MethodsForty-six patients with MD according to DSM-IV were included for this study. Patients were treated as clinically indicated. Depression severity was assessed by HAMD-17 by trained raters from baseline to week 6 in weekly intervals. Serum at each visit (baseline, V1-V6) was obtained from whole blood after centrifugation with 1.000…

medicine.medical_specialtySerum concentrationPsychiatry and Mental healthEndocrinologynervous systemInternal medicinemedicineAntidepressantIn patientsense organsskin and connective tissue diseasesPsychiatryPsychologyDepression (differential diagnoses)Whole bloodEuropean Psychiatry
researchProduct

Störungsorientierte, evidenzbasierte Psychotherapieverfahren am Beispiel der Borderline-Persönlichkeitsstörung

2012

Die Behandlung psychischer Storungen mittels Psychotherapie hat sich in den beiden letzten Jahrzehnten kontinuierlich hin zu storungsorientierten, evidenzbasierten Verfahren entwickelt und zumindest im wissenschaftlichen Bereich das Denken in Psychotherapieschulen abgelost. Diese neuen Entwicklungen werden anhand der storungszentrierten und evidenzbasierten psychotherapeutischen Behandlungsverfahren der Borderline-Personlichkeitsstorung nachvollzogen und diskutiert. Aus den Erfahrungen in der Psychotherapieforschung zu Personlichkeitsstorungen werden programmatische Empfehlungen zur zukunftigen Weiterentwicklung der Psychotherapieforschung und der Finanzierung von Psychotherapie gegeben.

researchProduct

Non‐Pharmacologic Multicomponent Interventions Preventing Delirium in Hospitalized People

2020

BACKGROUND/OBJECTIVES Delirium is a common neurobehavioral complication in hospitalized patients with a high prevalence in various clinical settings. Prevention of delirium is critical due to its common occurrence and associated poor outcomes. Our objective was to evaluate the efficacy of multicomponent interventions in preventing incident delirium in hospitalized patients at risk. DESIGN Systematic review and meta-analysis. SETTING Hospital. PARTICIPANTS We included a study if it was a randomized controlled trial and was evaluating effects of coordinated non-pharmacologic multicomponent interventions in the prevention of delirium. MEASUREMENTS We performed a systematic literature search in…

Malemedicine.medical_specialty610 Medizinmulticomponent interventions ; delirium ; prevention ; non-pharmacologic interventionslaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallaw610 Medical sciencesOutcome Assessment Health Caremental disordersmedicineHumans030212 general & internal medicineAgedRandomized Controlled Trials as TopicAged 80 and overInpatientsInpatient mortalitybusiness.industryIncidenceIncidence (epidemiology)Multicomponent interventionsDeliriumMiddle AgedAccidentalEmergency medicineDeliriumFemalePreventive MedicineGeriatrics and Gerontologymedicine.symptomComplicationbusiness030217 neurology & neurosurgeryIndependent livingJournal of the American Geriatrics Society
researchProduct

Cortical network mechanisms of response inhibition

2020

SummaryBoth the right inferior frontal gyrus (rIFG) and the pre-supplementary motor area (pre-SMA) are crucial for successful response inhibition. However, the particular functional roles of those two regions have been controversially debated for more than a decade now. It is unclear whether the rIFG directly initiates stopping or serves an attentional function, whereas the stopping is triggered by the pre-SMA. The current multimodal MEG/fMRI study sought to clarify the role and temporal activation order of both regions in response inhibition using a selective stopping task. This task dissociates inhibitory from attentional processes. Our results reliably reveal a temporal precedence of rIF…

0303 health sciences03 medical and health sciences0302 clinical medicineMotor areaRight inferior frontal gyrusCortical networkInhibitory postsynaptic potentialPsychologyNeuroscience030217 neurology & neurosurgeryResponse inhibition030304 developmental biology
researchProduct

Pharmacological interventions for schizoid personality disorder

2014

Reason for withdrawal from publication Authors have made no progress with this protocol in over three years due to difficulties with identifying potentially suitable studies. The protocol has been withdrawn. To view the published versions of this article, please click the 'Other versions' tab.

Protocol (science)PsychotherapistPharmacological interventionsSchizoid personality disordermedicinePsychologymedicine.diseasePersonality disordersClinical psychology
researchProduct

Early life stress stimulates hippocampal reelin gene expression in a sex-specific manner: Evidence for corticosterone-mediated action

2010

Early life stress predisposes to the development of psychiatric disorders. In this context the hippocampal formation is of particular interest, because it is affected by stress on the structural and cognitive level. Since little is known how early life stress is translated on the molecular level, we mimicked early life stress in mouse models and analyzed the expression of the glycoprotein Reelin, a master molecule for development and differentiation of the hippocampus. From postnatal day 1 (P1) to P14, mouse pups were subjected to one of the following treatments: nonhandling (NH), handling (H), maternal separation (MS), and early deprivation (ED) followed by immediate (P15) or delayed (P70)…

MaleCell Adhesion Molecules NeuronalCognitive NeuroscienceGene ExpressionCell CountNerve Tissue ProteinsContext (language use)Hippocampal formationHippocampusMiceCajal–Retzius cellchemistry.chemical_compoundSex FactorsCorticosteronemedicineAnimalsRNA MessengerReelinBrain-derived neurotrophic factorExtracellular Matrix ProteinsMaternal deprivationbiologyMaternal DeprivationSerine EndopeptidasesDAB1Reelin Proteinmedicine.anatomical_structurenervous systemchemistrybiology.proteinFemaleCorticosteroneNeuroscienceStress PsychologicalHippocampus
researchProduct

Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D2 /D3 dopamine system

2016

Investigations on the acute effects of alcohol in the human mesolimbic dopamine D2 /D3 receptor system have yielded conflicting results. With respect to the effects of alcohol on extrastriatal D2 /D3 dopamine receptors no investigations have been reported yet. Therefore we applied PET imaging using the postsynaptic dopamine D2 /D3 receptor ligand [18 F]fallypride addressing the question, whether intravenously applied alcohol stimulates the extrastriatal and striatal dopamine system. We measured subjective effects of alcohol and made correlation analyses with the striatal and extrastriatal D2 /D3 binding potential. Twenty-four healthy male μ-opioid receptor (OPRM1)118G allele carriers underw…

0301 basic medicinePharmacologymedicine.medical_specialtyMedicine (miscellaneous)D3 dopamine receptor binding03 medical and health sciencesPsychiatry and Mental health030104 developmental biology0302 clinical medicineEndocrinologyFallyprideDopamine receptorDopamine receptor D3DopamineInternal medicineDopamine receptor D2medicineOrbitofrontal cortexPsychologyPrefrontal cortexNeuroscience030217 neurology & neurosurgerymedicine.drugAddiction Biology
researchProduct

Group Therapy Module to Enhance Self-Esteem in Patients with Borderline Personality Disorder: A Pilot Study

2010

Psychotherapeutic treatments of borderline personality disorder (BPD) often focus on severe behavioral problems. Until now, few techniques have been developed to specifically address low self-esteem in BPD. We developed a 6-session psychoeducative group therapy module to treat low self-esteem in BPD patients. After developing and piloting the therapy module, a controlled outpatient pilot study was performed. Nineteen female BPD patients participated in the group module after discharge from an inpatient DBT program. Twenty-four female BPD patients served as controls. Outcome was assessed by different self-esteem measures. Results showed a greater improvement in self-esteem in the interventio…

Adultmedicine.medical_treatmentmedia_common.quotation_subjectAftercarePilot ProjectsComorbidityIntervention groupbehavioral disciplines and activitiesGroup psychotherapyPatient Education as TopicBehavior TherapyBorderline Personality Disordermental disordersmedicineHumansIn patientBorderline personality disordermedia_commonDepressive Disorder MajorSelf-esteemAfter dischargemedicine.diseaseComorbidityPatient DischargeSelf ConceptClinical PsychologyAdjunctive treatmentPsychotherapy GroupFemalePsychologyFollow-Up StudiesClinical psychologyInternational Journal of Group Psychotherapy
researchProduct

Author response: Right inferior frontal gyrus implements motor inhibitory control via beta-band oscillations in humans

2021

PhysicsBeta bandRight inferior frontal gyrusInhibitory controlNeuroscience
researchProduct

Lack of modulating effects of the COMT Val158Met polymorphism on the association of serious life events (SLE) and impulsivity in patients with Border…

2009

Adultmedicine.medical_specialtyPolymorphism GeneticLife eventsValineCatechol O-MethyltransferaseImpulsivitymedicine.diseaseLife Change EventsPsychiatry and Mental healthMethionineBorderline Personality DisorderPolymorphism (computer science)Impulsive BehaviormedicineHumansIn patientmedicine.symptomPsychiatryPsychologyAssociation (psychology)Borderline personality disorderGenetic Association StudiesBiological PsychiatryJournal of Psychiatric Research
researchProduct

Pharmacological interventions for avoidant personality disorder

2014

Reason for withdrawal from publication Authors have made no progress with this protocol in over two years due to difficulties with identifying potentially suitable studies. The protocol has been withdrawn. To view the published versions of this article, please click the 'Other versions' tab.

Protocol (science)business.industrymedicinePsychological interventionAvoidant personality disordermedicine.diseasebusinessPersonality disordersClinical psychology
researchProduct

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders.

2007

These practical guidelines for the biological treatment of personality disorders in primary care settings were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). They embody the results of a systematic review of all available clinical and scientific evidence pertaining to the biological treatment of three specific personality disorders, namely borderline, schizotypal and anxious/avoidant personality disorder in addition to some general recommendations for the whole field. The guidelines cover disease definition, classification, epidemiology, course and current knowledge on biological underpinnings, and provide a detailed overview …

medicine.medical_specialtymedia_common.quotation_subjectSadistic personality disorderAvoidant personality disorderPersonality DisordersSchizotypal Personality DisorderBorderline Personality DisordermedicinePersonalityHumansPsychiatryBorderline personality disorderBiological PsychiatrySocieties Medicalmedia_commonPsychiatryEvidence-Based Medicinemedicine.diseaseSchizotypal personality disorderPersonality disordersAntidepressive AgentsPsychotherapyPsychiatry and Mental healthBiological psychiatryPsychologyPsychopathologyClinical psychologyAntipsychotic AgentsThe world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
researchProduct

State dependent posterior hippocampal volume increases in patients with major depressive disorder.

2011

Abstract Background The hippocampal formation has been implicated in etiology and therapy response in major depressive disorder (MDD). However, prospective longitudinal studies investigating volumes in hippocampal subregions and their association with clinical findings are still lacking. Methods Global and regional hippocampal volumes and neuropsychological performance were assessed longitudinally in 15 young patients with unipolar early onset MDD who responded to therapy and 13 matched healthy control subjects. Results Although volumes at baseline did not differ between groups, patients with MDD showed significant posterior hippocampal volume increases during the treatment course (mean obs…

AdultMalemedicine.medical_specialtyHippocampusHippocampal formationNeuropsychological TestsHippocampusYoung AdultInternal medicineNeuroplasticitymedicineHumansLongitudinal StudiesProspective StudiesDepressive Disorder MajorNeuronal PlasticityNeuropsychologyOrgan SizeMiddle Agedmedicine.diseaseMagnetic Resonance ImagingAntidepressive AgentsPsychiatry and Mental healthClinical PsychologyCase-Control StudiesEtiologyCardiologyHippocampal volumeAntidepressantMajor depressive disorderFemalePsychologyNeuroscienceJournal of affective disorders
researchProduct

Psychological interventions for resilience enhancement in adults

2017

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of resilience‐enhancing interventions in clinical and non‐clinical populations.

Medicine General & Introductory Medical Sciences03 medical and health sciences0302 clinical medicinebusiness.industryApplied psychologyeducationPsychological interventionMedicinePharmacology (medical)030212 general & internal medicinebusinessResilience (network)030217 neurology & neurosurgery
researchProduct

Pharmacological Neuroenhancement, Perceived Stress, and Resilience in Spine Surgeons–A Cross-Sectional Survey

2022

Background Spine surgeons are usually exposed to high workload and demanding work conditions. Although the relationship between pharmacological neuroenhancement (PNE) and resilience (i.e., the ability to recover from stress), as well as perceived stress and resilience-enhancing factors, has been investigated in the general population, less is known about the impact of those factors in spine surgeons. This study aimed to close that gap by investigating the relationship between PNE use and resilience, perceived stress, or resilience-enhancing factors in spine surgeons. Methods We conducted a cross-sectional survey in a sample of 582 spine surgeons in German-speaking countries (Austria, German…

Surgeonseducation.field_of_studymedicine.medical_specialtyCross-sectional studybusiness.industrymedia_common.quotation_subjectPopulationPsychological interventionPerceived Stress ScaleWorkloadOdds ratioConfidence intervalCross-Sectional StudiesGermanySurveys and QuestionnairesPhysical therapyHumansMedicineSurgeryNeurology (clinical)Psychological resiliencebusinesseducationStress Psychologicalmedia_commonWorld Neurosurgery
researchProduct

A combined marker of early non-improvement and the occurrence of melancholic features improve the treatment prediction in patients with Major Depress…

2017

Abstract Background Early Improvement of depressive symptoms within two weeks of antidepressant treatment is a highly sensitive but less specific predictor of later treatment outcome. The aim of this study was to identify clinical features at treatment initiation which are associated with early improvement and non-improvement as well as to identify variables predicting non-remission in patients showing an early improvement. Methods 889 patients with a major depressive episode according to DSM-IV who had participated in an antidepressant treatment trial served as study sample. Clinical predictors (demographic variables, psychopathology, comorbid disorders) were analysed in 698 (79%) early im…

AdultMalemedicine.medical_specialtyComorbidityAvoidant personality disorderPatient ReadmissionSeverity of Illness IndexSuicidal Ideation03 medical and health sciences0302 clinical medicineRisk FactorsRating scaleInternal medicinemedicineHumansMajor depressive episodePsychiatryAtypical depressionDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryMiddle Agedmedicine.diseaseAntidepressive Agents030227 psychiatryPsychiatry and Mental healthClinical PsychologyTreatment OutcomeMajor depressive disorderAntidepressantFemalemedicine.symptombusiness030217 neurology & neurosurgeryPsychopathologyJournal of Affective Disorders
researchProduct

Interventionen zur Resilienzförderung bei Erwachsenen

2019

ZusammenfassungResilienz bezeichnet die Aufrechterhaltung bzw. rasche Wiederherstellung der psychischen Gesundheit während oder nach stressvollen Lebensumständen. Aktuelle Forschungsergebnisse legen nahe, dass Resilienz dynamisch ist und trainiert werden kann. Obwohl Interventionen zur Stärkung der Resilienz häufig zur Gesundheitsförderung bei verschiedenen Zielgruppen eingesetzt werden, ist deren Effektivität jedoch kaum systematisch untersucht. Diese Übersichtsarbeit beurteilt narrativ die Ergebnisse 4 systematischer Reviews und Metaanalysen zu Resilienzinterventionen bei Erwachsenen und fasst die Evidenz aus den randomisiert-kontrollierten Primärstudien (N=44) zusammen. Insgesamt erzielt…

Psychiatry and Mental healthClinical PsychologyApplied PsychologyPPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie
researchProduct

Pharmacological interventions for schizotypal personality disorder

2014

Reason for withdrawal from publication Authors have made no progress with this protocol in over a year due to difficulties with identifying potentially suitable studies. The protocol has been withdrawn. To view the published versions of this article, please click the 'Other versions' tab.

Protocol (science)medicine.medical_specialtyPsychotherapistPharmacological interventionsgenetic structuresbusiness.industryComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKSmedicineAlternative medicinemedicine.diseasebusinessSchizotypal personality disorderArticle
researchProduct

Neurochemical alterations in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder

2010

Borderline personality disorder (BPD) is associated with structural and functional brain changes. Recent models and findings refer to alterations of glutamate and total N-acetylaspartate (tNAA) in this condition.Absolute quantities of tNAA, creatine, glutamate, glutamine, myoinositol and total choline were measured using 3 Tesla magnetic resonance spectroscopy of the left anterior cingulate cortex and the left cerebellum in 14 unmedicated women with BPD and comorbid attention-deficit hyperactivity disorder (ADHD) and 18 healthy women. Both groups were matched with respect to age, education and premorbid intelligence.In the anterior cingulate, we found significantly higher tNAA and glutamate…

AdultCerebellummedicine.medical_specialtyMagnetic Resonance SpectroscopyGlutamineGlutamic Acid610 Medicine & health10056 Clinic for Clinical and Social Psychiatry Zurich West (former)CreatineGyrus Cingulibehavioral disciplines and activitiesCholine2738 Psychiatry and Mental Healthchemistry.chemical_compoundGlutamatergicNeurochemicalBorderline Personality DisorderCerebellumInternal medicinemental disordersmedicineHumansAttention deficit hyperactivity disorderBorderline personality disorderBiological PsychiatryBrain ChemistryAspartic AcidGlutamate receptorCreatinemedicine.diseaseGlutaminePsychiatry and Mental healthmedicine.anatomical_structureEndocrinologychemistryAttention Deficit Disorder with HyperactivityCase-Control StudiesPsychology2803 Biological PsychiatryInositolClinical psychologyThe World Journal of Biological Psychiatry
researchProduct

AS14-02 - Common and distinct treatment elements in psychotherapies for borderline personality disorder

2012

Introduction Borderline personality disorder (BPD) is defined as “a pervasive pattern of instability of interpersonal relationships, self-image, affects, and marked impulsivity” (DSM-IV-TR; APA, 2000). These very characteristics make it difficult to establish firm therapeutic relationships and keep patients in treatment. In recent decades, a number of new psychotherapeutic approaches have been developed in order to meet these specific challenges and demands. To date, there is evidence of efficacy for various treatments, as data of a recent systematic review and meta-analysis of our working group indicate. Objectives To give an overview of all psychotherapeutic treatments investigated in ran…

PsychotherapistPsychodynamicsmedicine.diseaseImpulsivityExperiential learningTreatment characteristicsTherapeutic relationshipPsychiatry and Mental healthInterpersonal relationshipTreatment intensitymedicinemedicine.symptomPsychologyBorderline personality disorderClinical psychologyEuropean Psychiatry
researchProduct

Association analysis between gene variants of the tyrosine hydroxylase and the serotonin transporter in borderline personality disorder.

2010

For patients with borderline personality disorder (BPD), we previously reported an independent effect of the catechol-o-methyl-transferase (COMT) low-activity (Met(158)) allele and an interaction with the low-expression allele of the deletion/insertion (short/long or S/L, resp.) polymorphism in the serotonin transporter-linked promoter region (5-HTTLPR). The purpose of the present study was to extend these findings to the tyrosine hydroxylase (TH) Val(81)Met single nucleotide polymorphism (SNP), the 5-HTTLPR S/L polymorphism incorporating the recently described functional A/G SNP within the long allele of the 5-HTTLPR (rs25531) as well as the variable number of tandem repeat (VNTR) polymorp…

medicine.medical_specialtyGenotypeTyrosine 3-MonooxygenaseGenome-wide association studySingle-nucleotide polymorphismCatechol O-MethyltransferasePolymorphism Single NucleotidePolymorphism (computer science)Borderline Personality DisorderInternal medicinemental disordersGenotypemedicineSNPHumansAlleleBiological PsychiatrySerotonin transporterAllelesGenetic associationGeneticsSerotonin Plasma Membrane Transport ProteinsbiologyGenetic VariationDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthEndocrinologyCase-Control Studiesbiology.proteinPsychologyGenome-Wide Association StudyThe world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
researchProduct

Association analysis of SCN9A gene variants with borderline personality disorder

2008

Borderline personality disorder (BPD) is a serious psychiatric disorder affecting about 1-2% of the general population. Key features of BPD are emotional instability, strong impulsivity, repeated self-injurious behavior (SIB) and dissociation. In the etiology of BPD and its predominant symptoms, genetic factors have been suggested. The voltage-gated sodium channel Nav1.7 is expressed in sensory neurons and in the hippocampus, a key region of the limbic system probably dysfunctional in BPD and dissociative disorders. The alpha-subunit of Nav1.7 is encoded by the SCN9A gene on chromosome 2 and variations of SCN9A can lead to complete inability to sense pain. The aim of the present study was t…

AdultGenetic MarkersMaleOncologyCandidate genemedicine.medical_specialtyPopulationSingle-nucleotide polymorphismImpulsivityPolymorphism Single Nucleotidebehavioral disciplines and activitiesBorderline Personality DisorderInternal medicinemental disordersmedicineHumansDissociative disordersSex DistributioneducationBorderline personality disorderBiological PsychiatryGenetic associationPsychiatric Status Rating ScalesGeneticseducation.field_of_studymedicine.diseasePsychiatry and Mental healthHaplotypesCase-Control StudiesFemaleSCN9A Genemedicine.symptomPsychologyJournal of Psychiatric Research
researchProduct

Pharmacotherapy of Borderline Personality Disorder: A Metaanalysis of Randomised Controlled Trials

2009

Background:In Borderline Personality Disorder (BPD), pharmacotherapy is used for the treatment of specific BPD pathology facets, such as cognitive-perceptual, affective, or impulsivity symptoms. Due to the polymorphic phenomenology of the disorder, different classes of drugs are used, e.g., antipsychotics, antidepressants, or mood stabilizers.Aims:To evaluate the up-to-date evidence of drug treatment efficacy for BPD.Method:A systematic review and metaanalysis of randomised controlled trials was done. All randomised comparisons of drug vs. placebo, drug vs. drug, or drug vs. a combination of drugs in adult BPD patients were eligible for inclusion. Outcomes comprised BPD core pathology as de…

medicine.medical_specialtymedicine.medical_treatmentImpulsivitymedicine.diseasePsychiatry and Mental healthMoodTolerabilitymedicineAnxietymedicine.symptomAdverse effectPsychiatryAntipsychoticPsychologyBorderline personality disorderPsychopathologyClinical psychologyEuropean Psychiatry
researchProduct

Longitudinal CSF proteome profiling in mice to uncover the acute and sustained mechanisms of action of rapid acting antidepressant (2R,6R)-hydroxynor…

2021

Delayed onset of antidepressant action is a shortcoming in depression treatment. Ketamine and its metabolite (2R,6R)-hydroxynorketamine (HNK) have emerged as promising rapid-acting antidepressants. However, their mechanism of action remains unknown. In this study, we first described the anxious and depression-prone inbred mouse strain, DBA/2J, as an animal model to assess the antidepressant-like effects of ketamine and HNK in vivo. To decode the molecular mechanisms mediating HNK's rapid antidepressant effects, a longitudinal cerebrospinal fluid (CSF) proteome profiling of its acute and sustained effects was conducted using an unbiased, hypothesis-free mass spectrometry-based proteomics app…

ProteomicsNeurophysiology and neuropsychologyanimal structuresHydroxynorketaminePhysiologyGlucocorticoid receptor signalingAntidepressantCSFNeurosciences. Biological psychiatry. NeuropsychiatryBiologyPharmacologyProteomicsBiochemistryCellular and Molecular NeuroscienceEndocrinologyGlucocorticoid receptorNeurotrophic factorsmedicineOriginal Research ArticleKetamine ; CSF ; Antidepressant ; (2R6R)-Hydroxynorketamine ; Glucocorticoid receptor signaling ; ProteomicsRC346-429Molecular BiologyPI3K/AKT/mTOR pathwayEndocrine and Autonomic SystemsQP351-495Mechanism of action(2R6R)-Hydroxynorketamineembryonic structuresAntidepressantKetamineNeurology. Diseases of the nervous systemmedicine.symptomSignal transductionRC321-571Neurobiology of Stress
researchProduct

Psychological interventions to foster resilience in healthcare professionals.

2020

Background Resilience can be defined as the maintenance or quick recovery of mental health during or after periods of stressor exposure, which may result from a potentially traumatising event, challenging life circumstances, a critical life transition phase, or physical illness. Healthcare professionals, such as nurses, physicians, psychologists and social workers, are exposed to various work-related stressors (e.g. patient care, time pressure, administration) and are at increased risk of developing mental disorders. This population may benefit from resilience-promoting training programmes. Objectives To assess the effects of interventions to foster resilience in healthcare professionals, t…

AdultMalemedicine.medical_specialtymedia_common.quotation_subjectHealth PersonnelPopulationPsychological interventionAllied Health Personnel03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Health caremedicineHumansPharmacology (medical)030212 general & internal medicineeducationmedia_commonRandomized Controlled Trials as Topiceducation.field_of_studyCognitive Behavioral Therapybusiness.industryFeatured ArticlesStressorMiddle AgedResilience PsychologicalMental healthOccupational DiseasesFamily medicineMeta-analysisFemalePsychological resiliencebusinessMindfulness030217 neurology & neurosurgeryStress PsychologicalThe Cochrane database of systematic reviews
researchProduct

Neural correlates of interference inhibition, action withholding and action cancelation in adult ADHD

2011

Attention-Deficit/Hyperactivity Disorder (ADHD) is marked by inhibitory and attentional deficits which can persist into adulthood. Those deficits have been associated with dysfunctional fronto-striatal and fronto-parietal circuits. The present study sought to delineate neural correlates of component specific inhibitory deficits in adult ADHD using functional magnetic resonance imaging (fMRI). 20 adult ADHD patients and 24 matched healthy controls were included. Brain activation was assessed during three stages of behavioral inhibition, i.e. interference inhibition (Simon task), action withholding (Go/no-go task) and action cancelation (Stop-signal task). Behaviorally, ADHD patients were aff…

AdultMaleNeuroscience (miscellaneous)Neuropsychological TestsInhibitory postsynaptic potentialInterference (genetic)behavioral disciplines and activitiesBrain mappingExecutive FunctionYoung AdultSurveys and Questionnairesmental disordersImage Processing Computer-AssistedReaction TimeBiological neural networkmedicineHumansRadiology Nuclear Medicine and imagingYoung adultBrain MappingNeural correlates of consciousnessmedicine.diagnostic_testMagnetic Resonance ImagingOxygenInhibition PsychologicalPsychiatry and Mental healthAction (philosophy)Attention Deficit Disorder with HyperactivityLinear ModelsFemaleCognition DisordersPsychologyFunctional magnetic resonance imagingNeuroscienceCognitive psychologyPsychiatry Research: Neuroimaging
researchProduct

Systematic review of psychotherapeutic treatments for “minor” personality disorders

2011

IntroductionAmong personality disorders (PDs), antisocial and borderline personality disorder are well-studied. However, the remaining PDs (in the following called “minor PDs”) pose major problems in everyday-health care settings. People affected often present with additional axis-l disorders such as substance-related, mood or anxiety disorders, and are among those most difficult to treat.ObjectivesTo systematically review the current evidence of psychotherapeutic treatments for “minor” personality disordersMethodsIn the context of Cochrane Collaboration reviews for Cluster A, B and C PDs, exhaustive literature searches were done to identify the current RCT evidence for PD treatments. The e…

medicine.medical_specialtyContext (language use)Minor (academic)Disease clustermedicine.diseasePersonality disorderslaw.inventionPsychiatry and Mental healthMoodRandomized controlled triallawmedicineAnxietymedicine.symptomPsychologyPsychiatryBorderline personality disorderClinical psychologyEuropean Psychiatry
researchProduct

SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging☆

2008

Statistical comparisons of [(18)F]FDG PET scans between healthy subjects and patients with Alzheimer's disease (AD) or amnestic mild cognitive impairment (aMCI) using Statistical Parametric Mapping (SPM) usually require normalization of regional tracer uptake via ROIs defined using additional software. Here, we validate a simple SPM-based method for count normalization. FDG PET scans of 21 mild, 15 very mild AD, 11 aMCI patients and 15 age-matched controls were analyzed. First, we obtained relative increases in the whole patient sample compared to controls (i.e. areas relatively preserved in patients) with proportional scaling to the cerebral global mean (CGM). Next, average absolute counts…

MaleNormalization (statistics)Agingmedicine.medical_specialtyPathologyCognitive NeuroscienceLogistic regressionStatistical parametric mappingNeuroimagingAlzheimer DiseaseFluorodeoxyglucose F18Internal medicineImage Interpretation Computer-AssistedmedicineHumansDementiaHealthy agingRadionuclide ImagingCognitive impairmentAgedRetrospective StudiesBrain Mappingmedicine.diagnostic_testBrainmedicine.diseaseNeurologyPositron emission tomographyCardiologyFemaleCognition DisordersPsychologyAlgorithmsNeuroImage
researchProduct

Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depressio…

2011

Abstract In Major Depressive Disorder, a growing data base suggests that the onset of antidepressants’ action can be detected by improvement of depressive symptoms in the first 10–14 days of treatment. Previous studies showed that the mean concentration of the brain-derived neurotrophic factor (BDNF) in blood increases during antidepressant treatment and positively correlates with amelioration of MDD symptoms. We previously showed an association between very early changes of the serum BDNF concentration and treatment outcome ( Tadic et al., 2011 . Prog Neuropsychopharmacol Biol Psychiatry 35, 415–420). However, no study has yet investigated whether BDNF concentration in plasma increases in …

OncologyAdultMalemedicine.medical_specialtyTime FactorsEnzyme-Linked Immunosorbent AssayCellular and Molecular NeuroscienceYoung AdultNeurotrophic factorsInternal medicineHamdmedicineHumansPsychiatryDepression (differential diagnoses)PharmacologyBrain-derived neurotrophic factorPsychiatric Status Rating ScalesDepressive Disorder MajorInpatientsBrain-Derived Neurotrophic FactorMiddle Agedmedicine.diseaseAntidepressive AgentsROC CurveLinear ModelsAntidepressantBiomarker (medicine)Major depressive disorderAnxietyFemalemedicine.symptomPsychologyNeuropharmacology
researchProduct

Do Mood Stabilizers Help in Borderline Personality Disorder?

2017

BackgroundDespite the relatively weak evidence base, individuals with borderline personality disorder are often treated with pharmacological interventions. Amongst the drugs, which have shown most promise, are mood stabilizers, which were one of the two drug classes with the most beneficial effects in a previous cochrane review though the robustness of findings was described as low (Stoffers et al., 2010). Here we present data on the latest evidence for mood stabilizers based on an updated cochrane review currently underway.MethodsA systematic review and meta-analysis of randomized controlled trials was conducted. All randomized comparisons of drug vs. placebo, drug vs. drug, or drug vs. a …

medicine.medical_specialtymedicine.diseasePersonality disorderslaw.inventionPsychiatry and Mental healthMoodTolerabilityRandomized controlled triallawmedicineAnxietymedicine.symptomPsychiatryAdverse effectPsychologyBorderline personality disorderPsychopathologyClinical psychologyEuropean Psychiatry
researchProduct

Early improvement of executive test performance during antidepressant treatment predicts treatment outcome in patients with Major Depressive Disorder

2017

Executive dysfunctions frequently occur in patients with Major Depressive Disorder and have been shown to improve during effective antidepressant treatment. However, the time course of improvement and its relationship to treatment outcome is unknown. The aim of the study was to assess the test performance and clinical outcome by repetitive assessments of executive test procedures during antidepressant treatment. Executive test performance was assessed in 209 –patients with Major Depressive Disorder (mean age 39.3 ± 11.4 years) and 84 healthy controls five times in biweekly intervals from baseline to week 8. Patients were treated by a defined treatment algorithm within the early medication c…

Malelcsh:MedicineSocial SciencesNeuropsychological TestsSeverity of Illness IndexExecutive FunctionCognition0302 clinical medicineMedicine and Health SciencesPsychologyVerbal fluency testlcsh:ScienceProspective cohort studyDepression (differential diagnoses)Cognitive ImpairmentMultidisciplinaryDepressionCognitive NeurologyPharmaceuticsCognitive flexibilityDrugsCognitionAntidepressantsMiddle AgedAntidepressive AgentsCognitive LinguisticsChemistryTreatment OutcomeNeurologyPhysical SciencesMajor depressive disorderFemaleResearch ArticleChemical ElementsAdultmedicine.medical_specialtyCognitive NeuroscienceLithium03 medical and health sciencesDrug TherapyNeuropsychologyRating scaleMental Health and PsychiatrySeverity of illnessmedicineHumansNeuropsychological TestingPharmacologyDepressive Disorder MajorMood Disordersbusiness.industrylcsh:RBiology and Life SciencesLinguisticsmedicine.disease030227 psychiatryCase-Control StudiesPhysical therapyCognitive Sciencelcsh:QbusinessPsychomotor Performance030217 neurology & neurosurgeryNeurosciencePLOS ONE
researchProduct

What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement

2012

Pharmacological cognitive enhancement (CE) is a topic of increasing public awareness. In the scientific literature on student use of CE as a study aid for academic performance enhancement, there are high prevalence rates regarding the use of caffeinated substances (coffee, caffeinated drinks, caffeine tablets) but remarkably lower prevalence rates regarding the use of illicit/prescription stimulants such as amphetamines or methylphenidate. While the literature considers the reasons and mechanisms for these different prevalence rates from a theoretical standpoint, it lacks empirical data to account for healthy students who use both, caffeine and illicit/prescription stimulants, exclusively f…

MaleNon-Clinical MedicinePsychopharmacologymedicine.medical_treatment610 Medizinlcsh:MedicineScientific literatureMedical LawSocial and Behavioral SciencesDrug UsersCognition610 Medical sciencesMedical SociologyHuman PerformancePsychologylcsh:ScienceNootropic AgentsProblem Solvingmedia_commonPsychiatryMultidisciplinarySubstance AbuseQualitative StudiesSubstance abuseMental HealthNeurologyHealth Education and AwarenessMedicineFemalePublic HealthBehavioral and Social Aspects of HealthResearch ArticleAdultMedical Ethicsmedicine.medical_specialtyDrugs and DevicesPrescription DrugsUniversitiesSubstance-Related DisordersClinical Research DesignScience Policymedia_common.quotation_subjectCognitive NeuroscienceDecision MakingNeuropharmacologyNeuropsychologyCaffeinemedicineHumansMedical prescriptionStudentsPsychiatryBiologyBehaviorHealth Care Policybusiness.industryIllicit DrugsAddictionlcsh:RCognitive PsychologyBioethicsmedicine.diseaseStimulantScience Educationlcsh:QCentral Nervous System StimulantsCitationAttributionbusinessLawMedical ethicsNeuroscience
researchProduct

Interaction between gene variants of the serotonin transporter promoter region (5-HTTLPR) and catecholO-methyltransferase (COMT) in borderline person…

2008

Borderline personality disorder (BPD) is characterized by a heterogeneous symptomatology with instability in impulse control, interpersonal relationships and self-image. BPD patients display repeated self-injury, chronic suicidal tendencies and emotional dysregulation, mainly dysregulation of negative affect. In its etiology, genetic and environmental factors have been suggested. Recently, an investigation in male healthy volunteers found gene–gene effects of the catechol-O-methyl-transferase (COMT) low-activity (Met158) and the low-expression allele of the deletion/insertion (short/long or S/L, respectively) polymorphism in the serotonin transporter-linked promoter region (5-HTTLPR) on the…

AdultMalemedicine.medical_specialtySingle-nucleotide polymorphismCatechol O-MethyltransferasePolymorphism Single Nucleotidebehavioral disciplines and activitiesCellular and Molecular NeuroscienceGene FrequencyGene interactionBorderline Personality DisorderInternal medicinemental disordersGenotypemedicineHumansAllelePromoter Regions GeneticBorderline personality disorderAllelesGenetics (clinical)Serotonin transporterSerotonin Plasma Membrane Transport ProteinsGeneticsCatechol-O-methyl transferasebiologybusiness.industryMiddle Agedmedicine.diseasePsychiatry and Mental healthLogistic ModelsEndocrinology5-HTTLPRbiology.proteinFemalebusinessAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics
researchProduct

Differential nociceptive deficits in patients with borderline personality disorder and self-injurious behavior: laser-evoked potentials, spatial disc…

2003

Approximately 70-80% of women meeting criteria for borderline personality disorder (BPD) report attenuated pain perception or analgesia during non-suicidal, intentional self-mutilation. The aim of this study was to use laser-evoked potentials (LEPs) and psychophysical methods to differentiate the factors that may underlie this analgesic state. Ten unmedicated female patients with BPD (according to DSM-IV) and 14 healthy female control subjects were investigated using brief radiant heat pulses generated by a thulium laser and five-channel LEP recording. Heat pulses were applied as part of a spatial discrimination task (two levels of difficulty) and during a mental arithmetic task. BPD patien…

AdultPain Thresholdmedicine.medical_specialtyLaser-Evoked PotentialsStatistics as TopicAudiologyElectroencephalographyNeuropsychological Testsbehavioral disciplines and activitiesDiscrimination PsychologicalBorderline Personality DisorderThreshold of painmedicineNoxious stimulusReaction TimeHumansEvoked potentialBorderline personality disorderEvoked PotentialsPain MeasurementAnalysis of VarianceHypoalgesiamedicine.diagnostic_testSecondary somatosensory cortexLasersElectroencephalographymedicine.diseaseAnesthesiology and Pain MedicineNeurologyAnesthesiaSpace PerceptionFemaleNeurology (clinical)PsychologySelf-Injurious BehaviorPain
researchProduct

Decoding the Mechanism of Action of Rapid-Acting Antidepressant Treatment Strategies: Does Gender Matter?

2019

Gender differences play a pivotal role in the pathophysiology and treatment of major depressive disorder. This is strongly supported by a mean 2:1 female-male ratio of depression consistently observed throughout studies in developed nations. Considering the urgent need to tailor individualized treatment strategies to fight depression more efficiently, a more precise understanding of gender-specific aspects in the pathophysiology and treatment of depressive disorders is fundamental. However, current treatment guidelines almost entirely neglect gender as a potentially relevant factor. Similarly, the vast majority of animal experiments analysing antidepressant treatment in rodent models exclus…

MalePsychotherapistsex differencemedia_common.quotation_subjectmedicine.medical_treatmentReviewelectroconvulsive therapyCatalysisNeglectlcsh:ChemistryInorganic Chemistryendocrinology03 medical and health sciences0302 clinical medicineElectroconvulsive therapygendermedicineAnimalsHumansPhysical and Theoretical Chemistrylcsh:QH301-705.5Molecular BiologySpectroscopyDepression (differential diagnoses)media_commonDepressive Disorder Majorantidepressantbusiness.industryOrganic ChemistryGeneral MedicineRapid-acting antidepressantrapid-actingmedicine.diseaseAntidepressive Agents030227 psychiatryComputer Science ApplicationsReview articleTreatment Outcomelcsh:Biology (General)lcsh:QD1-999(2R6R)-HydroxynorketaminedepressionTreatment strategyAntidepressantMajor depressive disorderFemaleKetaminebusiness030217 neurology & neurosurgery
researchProduct

Protective and Risk Factors for Mental Distress and Its Impact on Health-Protective Behaviors during the SARS-CoV-2 Pandemic between March 2020 and M…

2021

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is posing a global public health burden. These consequences have been shown to increase the risk of mental distress, but the underlying protective and risk factors for mental distress and trends over different waves of the pandemic are largely unknown. Furthermore, it is largely unknown how mental distress is associated with individual protective behavior. Three quota samples, weighted to represent the population forming the German COVID-19 Snapshot Monitoring study (24 March and 26 May 2020, and 9 March 2021 with &gt

medicine.medical_specialtyDistancingHealth Toxicology and Mutagenesismedia_common.quotation_subjectPopulationPsychological interventionArticleCognitive reappraisalMental distressRisk Factorsmental distressGermanyPandemicprotective factorsMedicineHumanseducationPsychiatryPandemicsresiliencemedia_commoneducation.field_of_studybusiness.industrySARS-CoV-2Public healthpandemicPublic Health Environmental and Occupational HealthRCOVID-19protective behaviorMedicinePsychological resiliencebusinessInternational Journal of Environmental Research and Public Health
researchProduct

A Group Intervention to Promote Resilience in Nursing Professionals: A Randomised Controlled Trial

2022

In this study, a new group intervention program to foster resilience in nursing professionals was tested for efficacy. In total, 72 nurses were recruited and randomised to either an intervention condition or to a wait list control condition. The study had a pre-test, post-test, follow-up design. The eight-week program targeted six resilience factors: cognitive flexibility, coping, self-efficacy, self-esteem, self-care, and mindfulness. Compared to the control group, the intervention group reported a significant improvement in the primary outcome mental health (measured with the General Health Questionnaire) from pre-test (M = 20.79; SD = 9.85) to post-test (M = 15.81; SD = 7.13) with an est…

mental health; resilience; nursing; occupational stress; psychotherapy; coping; randomised controlled trialHealth Toxicology and MutagenesisRPublic Health Environmental and Occupational HealthResilience Psychologicalresilience ; mental health ; nursing ; occupational stress ; coping ; randomised controlled trial ; psychotherapySelf EfficacyArticlepsychotherapycopingMental HealthnursingMedicineHumansMindfulnessresiliencerandomised controlled trialoccupational stressRetrospective StudiesInternational Journal of Environmental Research and Public Health
researchProduct

Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.

2008

&lt;i&gt;Background/Aims:&lt;/i&gt; Differences in the clinical presentation of men and women with borderline personality disorder (BPD) are of potential interest for investigations into the neurobiology, genetics, natural history, and treatment response of BPD. The purpose of this study was to investigate gender differences in axis I and axis II comorbidity and in diagnostic criteria in BPD patients. &lt;i&gt;Methods:&lt;/i&gt; 110 women and 49 men with BPD were assessed with the computer-based version of the Munich-Composite International Diagnostic Interview and the Structured Clinical Interview for DSM-IV Personality Disorders. Gender differences were investigated for the following outc…

NosologyAdultMalemedicine.medical_specialtyAnorexia NervosaBipolar DisorderCross-sectional studySubstance-Related DisordersComorbidityPersonality Assessmentbehavioral disciplines and activitiesPersonality DisordersYoung AdultSex FactorsBorderline Personality DisorderGermanymental disordersmedicineHumansIn patientYoung adultPsychiatryBorderline personality disorderDepressive DisorderMental DisordersFollow up studiesMiddle Agedmedicine.diseaseComorbidityAnxiety DisordersDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologyAlcoholismCross-Sectional StudiesFemalePersonality Assessment InventoryPsychologyPsychopathology
researchProduct

Psychological interventions for people with narcissistic personality disorder

2014

Reason for withdrawal from publication Authors have made no progress with this protocol in over a year due to difficulties with identifying potentially suitable studies. The protocol has been withdrawn.

Protocol (science)PsychotherapistNarcissistic personality disordermedicinePsychological interventionmedicine.diseasePsychologyPersonality disordersClinical psychology
researchProduct

Population-based validation of a German version of the Brief Resilience Scale.

2017

Smith and colleagues developed the Brief Resilience Scale (BRS) to assess the individual ability to recover from stress despite significant adversity. This study aimed to validate the German version of the BRS. We used data from a population-based (sample 1: n = 1.481) and a representative (sample 2: n = 1.128) sample of participants from the German general population (age ≥ 18) to assess reliability and validity. Confirmatory factor analyses (CFA) were conducted to compare one- and two-factorial models from previous studies with a method-factor model which especially accounts for the wording of the items. Reliability was analyzed. Convergent validity was measured by correlating BRS scores …

AdultMaleResearch ValidityAdolescentPsychometricsEmotions610 Medizinlcsh:MedicineSocial SciencesPsychological StressPrincipal component analysis ; Depression ; Anxiety ; Emotions ; Psychological stress ; Religion ; Mental health and psychiatry ; PsychometricsModels PsychologicalResearch and Analysis MethodsCultural AnthropologyYoung AdultMathematical and Statistical TechniquesSociology610 Medical sciencesGermanyMental Health and PsychiatryMedicine and Health SciencesHumansPsychologyStatistical Methodslcsh:ScienceAgedAged 80 and overPrincipal Component AnalysisMood DisordersDepressionlcsh:RBiology and Life SciencesMiddle AgedResilience PsychologicalResearch AssessmentReligionAnthropologyBehavior Rating ScaleMultivariate AnalysisPhysical Scienceslcsh:QFemaleMathematicsStatistics (Mathematics)Research ArticlePloS one
researchProduct

Prenatal adversity: a risk factor in borderline personality disorder?

2012

BackgroundPatients with borderline personality disorder (BPD) show a high prevalence of early adversity, such as childhood trauma. It has also been reported that prenatal adverse conditions, such as prenatal maternal stress, drug taking, tobacco smoking or medical complications, may be associated with an increased risk of mental disorders in the offspring. Prenatal adversity is investigated here for the first time as a potential risk factor in the diagnosis of BPD.MethodA total of 100 patients with a DSM-IV diagnosis of BPD and 100 matched healthy controls underwent semi-structured interviews about the course of pregnancy, maternal stressors, birth complications and childhood trauma. Furthe…

AdultMalemedicine.medical_specialtyAdolescentImpulsivityYoung AdultSocial supportBorderline Personality DisorderPregnancyRisk FactorsmedicineHumansBorderline personality disorderApplied PsychologyPregnancybusiness.industryObstetricsSmokingCase-control studyTraumatic stressSocial SupportOdds ratioMiddle AgedIdentity disturbancemedicine.diseasePregnancy ComplicationsPsychiatry and Mental healthLogistic ModelsMaternal ExposureCase-Control StudiesPrenatal Exposure Delayed EffectsFemalemedicine.symptombusinessClinical psychologyPsychological Medicine
researchProduct

Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons

Medicine(all)BMC Medicine
researchProduct

Disentangling common and specific neural subprocesses of response inhibition.

2012

article i nfo Response inhibition is disturbed in several disorders sharing impulse control deficits as a core symptom. Since response inhibition is a cognitively and neurally multifaceted function which has been shown to rely on differing neural subprocesses and neurotransmitter systems, further differentiation to define neurophys- iological endophenotypes is essential. Response inhibition may involve at least three separable cognitive sub- components, i.e. interference inhibition, action withholding, and action cancelation. Here, we introduce a novel paradigm - the Hybrid Response Inhibition task - to disentangle interference inhibition, action withholding and action cancelation and their…

AdultMaleCognitive NeuroscienceDecision MakingInferior frontal gyrusNeurotransmitter systemsYoung AdultmedicineHumansResponse inhibitionCerebral CortexCommunicationMotor areaArtificial neural networkmedicine.diagnostic_testbusiness.industryCognitionNeural InhibitionMagnetic Resonance ImagingInhibition PsychologicalNeurologyEndophenotypeFemaleNerve NetFunctional magnetic resonance imagingPsychologybusinessNeuroscienceNeuroImage
researchProduct

Dopamine D2/D3 receptor availability and venturesomeness.

2011

The construct of impulsivity is considered as a major trait of personality. There is growing evidence that the mesolimbic dopamine system plays an important role in the modulation of impulsivity and venturesomeness, the two key components within the impulsivity-construct. The aim of the present study was to explore an association between trait impulsivity measured with self-assessment and the dopaminergic neurotransmission as measured by positron emission tomography (PET) in a cohort of healthy male subjects. In vivo D2/D3 receptor availability was determined with [(18)F]fallypride PET in 18 non-smoking healthy subjects. The character trait impulsivity was measured using the Impulsiveness-V…

AdultMaleSelf-AssessmentPyrrolidinesStatistics as TopicNeuroscience (miscellaneous)Neuropsychological TestsImpulsivityStatistical parametric mappingPersonality AssessmentBrain mappingDevelopmental psychologyCohort StudiesYoung AdultRisk-TakingDopamine receptor D3Dopamine receptor D2Surveys and QuestionnairesmedicineHumansRadiology Nuclear Medicine and imagingTemporal cortexBrain MappingReceptors Dopamine D2BrainPsychiatry and Mental healthFallypridePositron-Emission TomographyBenzamidesImpulsive Behaviormedicine.symptomPersonality Assessment InventoryPsychologyNeurosciencePsychiatry research
researchProduct

Pharmacological interventions for people with histrionic personality disorder

2011

Reason for withdrawal from publication Authors have made no progress with this protocol in over a year due to difficulties with identifying potentially suitable studies. The protocol has been withdrawn. To view the published versions of this article, please click the 'Other versions' tab.

Protocol (science)Pharmacological interventionsHistrionic personality disordermedicinePsychologymedicine.diseaseClinical psychology
researchProduct

Impulsiveness and venturesomeness in German smokers.

2011

Introduction Cigarette smoking is a behavior, which is influenced by genetic, demographic, and psychological factors. A large body of research has examined the association of cigarette smoking variables with individual differences in personality traits. The aim of the current study was to replicate the findings of higher self-reported impulsivity in smokers compared with never-smokers in a German sample using Eysenck´s construct of impulsivity. Furthermore, it was intended to further the knowledge about associations between different self-reported impulsivity components and different smoking variables. Methods We used the Impulsiveness-Venturesomeness-Empathy questionnaire (I7) to measure s…

AdultMaleImpulsivityGermanCigarette smokingGermanySurveys and QuestionnairesmedicineHumansBig Five personality traitsDemographySmokingPublic Health Environmental and Occupational HealthNovelty seekingTobacco Use DisorderMiddle Agedlanguage.human_languageSmoking epidemiologyLogistic ModelsImpulsive Behaviorbehavior and behavior mechanismslanguageExploratory BehaviorTemperament and Character InventorySmoking statusFemalemedicine.symptomPsychologyClinical psychologyNicotinetobacco research : official journal of the Society for Research on Nicotine and Tobacco
researchProduct

Individual participant data systematic reviews with meta-analyses of psychotherapies for borderline personality disorder: A protocol

2020

AbstractIntroductionThe heterogeneity in people with BPD and the range of specialised psychotherapies means that people with certain BPD characteristics might benefit more or less from different types of psychotherapy. Identifying moderating characteristics of individuals is a key to refine and tailor standard treatments so they match the specificities of the individual patient. The objective of this is to improve the quality of care and the individual outcomes. Thus, the aim of the current reviews is to investigate potential predictors and moderating patient characteristics on treatment outcomes for patients with BPD.Methods and analysisOur primary meta-analytic method will be the one-stag…

Protocol (science)Systematic reviewIndividual participant dataTreatment outcomeCovariatemedicinePatient characteristicsPsychologymedicine.diseaseBorderline personality disorderClinical psychologyMultinomial logistic regression
researchProduct

Extraction of prefronto-amygdalar pathways by combining probability maps

2008

Many recent studies reported altered functional connectivity within the frontolimbic circuitry in a wide range of neuropsychiatric disorders. However, functional connectivity must rely on structural connections. In this study we applied a novel probabilistic fiber tracking method to assess the structural connectivity between the amygdala and different prefrontal brain regions in vivo. Twenty healthy subjects were investigated with diffusion tensor imaging. Probabilistic fiber tracking was started from the amygdala and different prefrontal brain regions. Resulting probability maps were combined using an extended multiplication of probabilistic maps to identify the most probable anatomical pa…

AdultExternal capsuleAdolescentNeuroscience (miscellaneous)Prefrontal CortexNerve Fibers MyelinatedAmygdalaBrain mappingYoung AdultNeural PathwaysBasal gangliamedicineHumansRadiology Nuclear Medicine and imagingPrefrontal cortexAnterior cingulate cortexProbabilityBrain MappingMiddle AgedAmygdalaDorsolateral prefrontal cortexPsychiatry and Mental healthDiffusion Magnetic Resonance Imagingmedicine.anatomical_structureFemaleNerve NetPsychologyNeuroscienceDiffusion MRIPsychiatry Research: Neuroimaging
researchProduct

Challenges in the Transition from In-Patient to Out-Patient Treatment in Depression

2020

Background Few data are available on the characteristics of inpatient treatment and subsequent outpatient treatment for depression in Germany. In this study, we aimed to characterize the inpatient and outpatient treatment phases, to determine the rates of readmission and mortality, and to identify risk factors. Methods We carried out a descriptive statistical analysis of routine administrative data from a large health-insurance carrier (BARMER). All insurees aged 18 to 65 who were treated in 2015 as inpatients on a psychiatry and psychotherapy service or on a psychosomatic medicine and psychotherapy service with a main diagnosis of depression were included in the analysis. Risk factors for …

education.field_of_studymedicine.medical_specialtybusiness.industryPopulationPsychosomatic medicineGeneral MedicineLogistic regression030227 psychiatry03 medical and health sciences0302 clinical medicinePharmacotherapyAmbulatory careHealth careEmergency medicineMedicineYoung adultbusinesseducation030217 neurology & neurosurgeryDepression (differential diagnoses)Deutsches Ärzteblatt international
researchProduct

Pharmakologisches Neuroenhancement: Substanzen und Epidemiologie

2012

General MedicinePsychiatrie und Psychotherapie up2date
researchProduct

The catechol o-methyltransferase (COMT) val158met polymorphism modulates the association of serious life events (SLE) and impulsive aggression in fem…

2009

Wagner S, Baskaya O, Anicker NJ, Dahmen N, Lieb K, Tadic A. The catechol o‐methyltransferase (COMT) val158met polymorphism modulates the association of serious life events (SLE) and impulsive aggression in female patients with borderline personality disorder (BPD). Objective: We analyzed i) the effects of serious life events (SLE) on impulsive aggression, and ii) modulating effects of the COMT Val158Met polymorphism on the association between SLEs and impulsive aggression in borderline personality disorder (BPD). Method: One hundred and twelve female BPD patients from Germany were included in this study. Impulsive aggression was assessed by the Buss‐Durkee‐Hostility Inventory (BDHI). Result…

Child abusemedicine.medical_specialtyCatechol-O-methyl transferaseAggressionPoison controlImpulsivitymedicine.diseasebehavioral disciplines and activitiesGenetic determinismPsychiatry and Mental healthSexual abusemental disordersmedicinemedicine.symptomPsychiatryPsychologyBorderline personality disorderActa Psychiatrica Scandinavica
researchProduct

Construct Validity and Population-Based Norms of the German Brief Resilience Scale (BRS).

2018

Abstract. The Brief Resilience Scale (BRS) measures the ability to recover from stress. To provide further evidence for construct validity of the German BRS and to determine population-based norms, a large sample (N = 1,128) representative of the German adult population completed a survey including the BRS and instruments measuring perceived stress and the resilience factors optimism, self-efficacy, and locus of control. Confirmatory factor analyses showed best model fit for a five-factor model differentiating the ability to recover from stress from the three resilience factors. On the basis of latent and manifest correlations, convergent and discriminant validity of the BRS were fair to g…

050103 clinical psychologyeducation.field_of_studyrepresentative sample05 social sciencesPopulationfungiConstruct validity050109 social psychologyPopulation basedlanguage.human_languageGermanPsychiatry and Mental healthClinical Psychologypredictorsnorm datalanguage0501 psychology and cognitive sciencesResilience scaleOriginal ArticlePsychologyeducationSocial psychologyBRSGerman versionEuropean journal of health psychology
researchProduct

Surprise: Unexpected Action Execution and Unexpected Inhibition Recruit the Same Fronto-Basal-Ganglia Network.

2020

Unexpected and thus surprising events are omnipresent and oftentimes require adaptive behavior such as unexpected inhibition or unexpected action. The current theory of unexpected events suggests that such unexpected events just like global stopping recruit a fronto-basal-ganglia network. A global suppressive effect impacting ongoing motor responses and cognition is specifically attributed to the subthalamic nucleus (STN). Previous studies either used separate tasks or presented unexpected, task-unrelated stimuli during response inhibition tasks to relate the neural signature of unexpected events to that of stopping. Here, we aimed to test these predictions using a within task design with i…

AdultMaleJournal Clubmedia_common.quotation_subjectPoison control03 medical and health sciencesYoung Adult0302 clinical medicinego/nogo task ; theory of unexpected events ; inferior frontal cortex ; response inhibition ; subthalamic nucleusNeural PathwaysmedicineReaction TimeHumans030304 developmental biologymedia_commonAdaptive behavior0303 health sciencesReactive inhibitionmedicine.diagnostic_testGeneral NeuroscienceNoveltyBrainCognitionMagnetic Resonance ImagingSurpriseInhibition PsychologicalUnexpected eventsFemaleFunctional magnetic resonance imagingPsychologyNeurosciencepsychological phenomena and processes030217 neurology & neurosurgeryPsychomotor PerformanceThe Journal of neuroscience : the official journal of the Society for Neuroscience
researchProduct

Reduced interhemispheric structural connectivity between anterior cingulate cortices in borderline personality disorder

2008

Functional and structural alterations of the anterior cingulate cortex (ACC), a key region for emotional and cognitive processing, are associated with borderline personality disorder (BPD). However, the interhemispheric structural connectivity between the left and right ACC and between other prefrontal regions in this condition is unknown. We acquired diffusion-tensor imaging data from 20 healthy women and 19 women with BPD and comorbid attention-deficit hyperactivity disorder (ADHD). Interhemispheric structural connectivity between both sides of the ACC, dorsolateral prefrontal cortices and medial orbitofrontal cortices was assessed by a novel probabilistic diffusion tensor-based fiber tra…

AdultCingulate cortexDorsumAdolescentCentral nervous systemNeuroscience (miscellaneous)610 Medicine & health10056 Clinic for Clinical and Social Psychiatry Zurich West (former)Corpus callosumGyrus Cingulibehavioral disciplines and activitiesFunctional LateralityCorpus CallosumYoung Adult2738 Psychiatry and Mental HealthBorderline Personality DisorderNeural Pathwaysmental disordersImage Processing Computer-AssistedmedicineHumans2741 Radiology Nuclear Medicine and ImagingRadiology Nuclear Medicine and imagingBorderline personality disorderAnterior cingulate cortexBrain MappingCognitionMiddle Agedmedicine.diseasePsychiatry and Mental healthDiffusion Magnetic Resonance Imagingmedicine.anatomical_structurenervous system2801 Neuroscience (miscellaneous)Case-Control StudiesFemalePsychologyNeuroscienceDiffusion MRI
researchProduct

Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students.

2013

STUDY OBJECTIVE: To estimate the 12-month prevalence of cognitive-enhancing drug use. DESIGN: Paper-and-pencil questionnaire that used the randomized response technique. SETTING: University in Mainz, Germany. PARTICIPANTS: A total of 2569 university students who completed the questionnaire. MEASUREMENTS AND MAIN RESULTS: An anonymous, specialized questionnaire that used the randomized response technique was distributed to students at the beginning of classes and was collected afterward. From the responses, we calculated the prevalence of students taking drugs only to improve their cognitive performance and not to treat underlying mental disorders such as attention-deficit-hyperactivity diso…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentUniversitiesSubstance-Related DisordersPoison controlSuicide preventionSurvey methodologyYoung AdultGermanySurveys and QuestionnairesInjury preventionEpidemiologymedicinePrevalenceHumansPharmacology (medical)Effects of sleep deprivation on cognitive performancePsychiatryStudentsNootropic Agentsbusiness.industryHuman factors and ergonomicsMiddle Agedmedicine.diseaseSubstance abuseFamily medicineFemalebusinessPharmacotherapy
researchProduct

Ambient Air Pollution Increases the Risk of Cerebrovascular and Neuropsychiatric Disorders through Induction of Inflammation and Oxidative Stress

2020

Exposure to ambient air pollution is a well-established determinant of health and disease. The Lancet Commission on pollution and health concludes that air pollution is the leading environmental cause of global disease and premature death. Indeed, there is a growing body of evidence that links air pollution not only to adverse cardiorespiratory effects but also to increased risk of cerebrovascular and neuropsychiatric disorders. Despite being a relatively new area of investigation, overall, there is mounting recent evidence showing that exposure to multiple air pollutants, in particular to fine particles, may affect the central nervous system (CNS) and brain health, thereby contributing to …

air pollutionneurological disordersAir pollutionReviewDisease010501 environmental sciencesGlobal Healthmedicine.disease_cause01 natural scienceslcsh:Chemistry0302 clinical medicineMedicineStrokelcsh:QH301-705.5SpectroscopyDepression (differential diagnoses)media_commonAir Pollutantscerebrovascular disordersGeneral MedicinestrokeComputer Science ApplicationsDisease Susceptibilitycerebrovascular disorders ; dementia ; oxidative stress ; mental disorders ; air pollution ; particulate matter ; inflammation ; neurological disorders ; strokePollutionmedicine.medical_specialtymedia_common.quotation_subjectCatalysisInorganic Chemistry03 medical and health sciencesEnvironmental healthAnimalsHumansDementiaPhysical and Theoretical ChemistryMolecular Biology0105 earth and related environmental sciencesInflammationparticulate matterbusiness.industryPublic healthOrganic ChemistryCOVID-19medicine.diseasemental disordersDisease Models AnimalOxidative Stresslcsh:Biology (General)lcsh:QD1-999business030217 neurology & neurosurgeryOxidative stressdementiaInternational Journal of Molecular Sciences
researchProduct

Rapid acting antidepressant (2R,6R)-hydroxynorketamine (HNK) targets glucocorticoid receptor signaling: a longitudinal cerebrospinal fluid proteome s…

2020

AbstractDelayed onset of antidepressant action is a shortcoming in depression treatment. Ketamine and its metabolite (2R,6R)-hydroxynorketamine (HNK) have emerged as promising rapidacting antidepressants. However, their mechanism of action remains unknown. In this study, we first described the anxious and depression-prone inbred mouse strain, DBA/2J, as a animal model to assess the antidepressant-like effects of ketamine and HNK in vivo. To decode the molecular mechanisms mediating HNK’s rapid antidepressant effects, a longitudinal cerebrospinal fluid (CSF) proteome profiling of its acute and sustained effects was conducted using an unbiased, hypothesis-free mass spectrometry-based proteomi…

Glucocorticoid receptorHydroxynorketamineMechanism of actionNeurotrophic factorsProteomemedicineSignal transductionPharmacologyBiologymedicine.symptomProteomicsPI3K/AKT/mTOR pathway
researchProduct

Molecular cause and functional impact of altered synaptic lipid signaling due to a prg‐1 gene SNP

2015

Loss of plasticity-related gene 1 (PRG-1), which regulates synaptic phospholipid signaling, leads to hyperexcitability via increased glutamate release altering excitation/inhibition (E/I) balance in cortical networks. A recently reported SNP in prg-1 (R345T/ mutPRG-1) affects ~5 million European and US citizens in a monoallelic variant. Our studies show that this mutation leads to a loss-of-PRG-1 function at the synapse due to its inability to control lysophosphatidic acid (LPA) levels via a cellular uptake mechanism which appears to depend on proper glycosylation altered by this SNP. PRG-1 +/ mice, which are animal correlates of human PRG-1 +/mut carriers, showed an altered cortical networ…

0301 basic medicineGeneticseducation.field_of_studySensory gatingPopulationGlutamate receptorLipid signalingBiologyCell biologySynapse03 medical and health scienceschemistry.chemical_compound030104 developmental biology0302 clinical medicinemedicine.anatomical_structurechemistryLysophosphatidic acidmedicineMolecular MedicineSignal transductionAutotaxineducation030217 neurology & neurosurgeryEMBO Molecular Medicine
researchProduct

Psychological interventions for people with histrionic personality disorder

2012

Reason for withdrawal from publication Authors have made no progress with this protocol in over a year due to difficulties with identifying potentially suitable studies. The protocol has been withdrawn. To view the published versions of this article, please click the 'Other versions' tab.

Protocol (science)Histrionic personality disordermedicinePsychological interventionmedicine.diseasePsychologyClinical psychology
researchProduct

Mental health and psychosocial support strategies in highly contagious emerging disease outbreaks of substantial public concern: A systematic scoping…

2021

Background Acute disease outbreaks such as the COVID-19 pandemic cause a high burden of psychological distress in people worldwide. Interventions to enable people to better cope with such distress should be based on the best available evidence. We therefore performed a scoping review to systematically identify and summarize the available literature of interventions that target the distress of people in the face of highly contagious disease outbreaks. Methods MEDLINE, Cochrane CENTRAL, Web of Science (January 2000 to May 7, 2020), and reference lists were systematically searched and screened by two independent reviewers. Quantitative and qualitative studies investigating the effects of psyc…

Viral Diseasespsychosocial supportEpidemiologymedicine.medical_treatmentPsychological interventionSocial SciencesPsychiatry and PsychologyDisease OutbreaksMedical ConditionsAdaptation PsychologicalPandemicHealth careMedicine and Health SciencesPsychologyMedicineMultidisciplinaryQRQualitative StudiesResilience PsychologicalContagious diseaseDistressInfectious DiseasesMental HealthResearch DesignMedicinePublic HealthCOVID-19 ; Medical risk factors ; Psychological stress ; Qualitative studies ; Mental health and psychiatry ; Post-traumatic stress disorder ; Psychological and psychosocial issues ; PandemicsResearch Articlemedicine.medical_specialtyHealth PersonnelSciencePsychological StressResearch and Analysis MethodsMental Health and PsychiatryPsychoeducationHumansinterventionsresiliencePandemicsPsychological and Psychosocial IssuesSARS-CoV-2business.industrypandemicPsychosocial Support SystemsBiology and Life SciencesCOVID-19Covid 19Evidence-based medicinemedicine.diseaseMental healthHealth CareMedical Risk FactorsFamily medicinescoping reviewbusinessPLoS ONE
researchProduct

Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response

2019

Obesity is one of the most prevalent somatic comorbidities of Major Depressive Disorder (MDD). We aimed to investigate the relationship between body mass index (BMI) and MDD, the symptomatology of the disorder as well as the outcome of antidepressant treatment.Early medication change (EMC) trial participants with BMI measurement (n = 811) were categorized according to WHO-criteria in normal or low weight (BMI  25), overweight (25- 30), and obese (≥30). Depression severity and BMI was assessed in weekly intervals up to 8 weeks. BMI at baseline and course of BMI during the study were investigated in linear regression models as possible moderators of therapy response. Possible moderators such …

AdultMalemedicine.medical_specialtyComorbidityOverweightWeight GainBody Mass IndexDepressive symptomatology03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansObesityDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryMiddle Agedmedicine.diseaseObesityAntidepressive Agents030227 psychiatryPsychiatry and Mental healthClinical PsychologyAntidepressantMajor depressive disorderFemalemedicine.symptombusinessWeight gainBody mass index030217 neurology & neurosurgeryJournal of Affective Disorders
researchProduct

Cannabis for Cognitive Enhancement as a New Coping Strategy? Results From a Survey of Students at Four Universities in Germany

2016

Cognitive Enhancement (CE) is often discussed in relation to stimulant drugs, such as amphetamines (AMPH). However, there is some evidence that cannabis (CAN) can be used for CE.This study compares the knowledge, prevalence, and perceived effects of and factors associated with the knowledge of or use of CAN versus AMPH for CE among undergraduate students at four German universities.A survey was taken of 1,538 students at four German universities. It investigated their knowledge and use of CAN and AMPH for CE as well as associated factors. Descriptive and analytic (Mann-Whitney-U test, Fisher's exact test, logistic regression) statistics were obtained using SPSS.Responses were obtained from …

medicine.medical_specialtyHealth (social science)UniversitiesLifetime prevalenceMedicine (miscellaneous)Logistic regressionGerman03 medical and health sciencesCognition0302 clinical medicineGermanySurveys and QuestionnairesAdaptation PsychologicalmedicineHumans030212 general & internal medicineStudentsPsychiatryCannabisbiologyPublic Health Environmental and Occupational HealthCognitionbiology.organism_classificationlanguage.human_language030227 psychiatryTest (assessment)Psychiatry and Mental healthExact testlanguageCannabisPsychologySubstance Use &amp; Misuse
researchProduct

Escitalopram for the prevention of peginterferon-alpha2a-associated depression in hepatitis C virus-infected patients without previous psychiatric di…

2012

BACKGROUND: Depression is a major complication during treatment of chronic hepatitis C virus (HCV) infection with interferon-alpha (IFN-alpha). It is unclear whether antidepressants can prevent IFN-induced depression in patients without psychiatric risk factors. OBJECTIVE: To examine whether preemptive antidepressant treatment with escitalopram can decrease the incidence or severity of depression associated with pegylated IFN-alpha in HCV-infected patients without a history of psychiatric disorders. DESIGN: Randomized, multicenter, double-blind, prospective, placebo-controlled, parallel-group trial. (ClinicalTrials.gov registration number: NCT00136318) SETTING: 10 university and 11 academic…

medicine.medical_specialtyPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineInternal MedicinemedicineEscitalopram030212 general & internal medicinePsychiatryDepression (differential diagnoses)business.industryIncidence (epidemiology)Absolute risk reductionGeneral MedicineHepatitis Cmedicine.disease3. Good healthTolerability030211 gastroenterology & hepatologybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologymedicine.drug
researchProduct

Physical Activity in Polluted Air—Net Benefit or Harm to Cardiovascular Health? A Comprehensive Review

2021

Both exposure to higher levels of polluted air and physical inactivity are crucial risk factors for the development and progression of major noncommunicable diseases and, in particular, of cardiovascular disease. In this context, the World Health Organization estimated 4.2 and 3.2 million global deaths per year in response to ambient air pollution and insufficient physical activity, respectively. While regular physical activity is well known to improve general health, it may also increase the uptake and deposit of air pollutants in the lungs/airways and circulation, due to increased breathing frequency and minute ventilation, thus increasing the risk of cardiovascular disease. Thus, determi…

medicine.medical_specialtyPhysiologyCardiovascular healthair pollutionClinical BiochemistryAir pollutionPhysical activityphysical activityContext (language use)ReviewRM1-950DiseaseHealth benefitsmedicine.disease_causeBiochemistrycardiovascular diseaseEnvironmental healthmedicineoxidative stressMolecular Biologyantioxidant defensebusiness.industryPublic healthCell BiologyHarminflammationTherapeutics. PharmacologybusinessAntioxidants
researchProduct

Smoking and Neuropsychiatric Disease-Associations and Underlying Mechanisms.

2021

Despite extensive efforts to combat cigarette smoking/tobacco use, it still remains a leading cause of global morbidity and mortality, killing more than eight million people each year. While tobacco smoking is a major risk factor for non-communicable diseases related to the four main groups—cardiovascular disease, cancer, chronic lung disease, and diabetes—its impact on neuropsychiatric risk is rather elusive. The aim of this review article is to emphasize the importance of smoking as a potential risk factor for neuropsychiatric disease and to identify central pathophysiological mechanisms that may contribute to this relationship. There is strong evidence from epidemiological and experiment…

medicine.medical_specialtyneuropsychiatric disorder ; smoking ; smoking-induced disease ; inflammation ; oxidative stressQH301-705.5DiseaseReviewCatalysisInorganic Chemistry03 medical and health sciences0302 clinical medicineRisk FactorsEpidemiologymedicineTobacco SmokingDementiaAnimalsHumans030212 general & internal medicinePhysical and Theoretical ChemistryCognitive declineRisk factorBiology (General)PsychiatryMolecular BiologyQD1-999SpectroscopyDepression (differential diagnoses)business.industryOrganic ChemistrySmokingsmoking-induced diseaseneuropsychiatric disorderGeneral Medicinemedicine.diseaseAnxiety DisordersComputer Science ApplicationsChemistryOxidative StressSchizophreniainflammationbusiness030217 neurology & neurosurgeryAnxiety disorderSignal TransductionInternational journal of molecular sciences
researchProduct

Are Treatment Gains Maintained? Long-term Psychological Interventions for Bordeline Personality Disorder

2017

IntroductionMany new approaches have been developed to treat borderline personality disorder (BPD) by means of psychotherapy. Though there is a clear research trend towards short-interventions, the evidence from randomised controlled trials (RCT) on longer-term programmes still accumulates. On the one hand, well-established treatments like Dialectical Behavior Therapy (DBT) or Mentalisation-Based Treatment (MBT) are now subject to real-world effectiveness studies; on the other hand, new dynamic approaches have been studied, lasting longer than 6 months.ObjectivesWe are currently updating the cochrane Collaboration review on psychological interventions for BPD. First findings on the effects …

medicine.medical_specialtymedia_common.quotation_subjectmedicine.medical_treatmentBehaviour therapyPsychological interventionmedicine.diseasePersonality disordersDialectical behavior therapylaw.inventionPsychiatry and Mental healthRandomized controlled triallawmedicinePersonalityAnxietymedicine.symptomPsychiatryPsychologyBorderline personality disordermedia_commonClinical psychologyEuropean Psychiatry
researchProduct

The Amount of Mitochondrial DNA in Blood Reflects the Course of a Depressive Episode

2016

AdultMalePsychiatric Status Rating ScalesGeneticsDepressive DisorderMitochondrial DNAbusiness.industryMiddle AgedBioinformaticsDNA Mitochondrial030227 psychiatryYoung Adult03 medical and health sciences0302 clinical medicineDisease ProgressionHumansMedicineFemaleLongitudinal Studiesbusiness030217 neurology & neurosurgeryBiological PsychiatryBiological Psychiatry
researchProduct

Influence of gender on cytokine induced depression and treatment

2021

Abstract Background Cytokine treatment with Interferon-alpha (IFN-α) represents a clinical model of immune associated depression, but it remains unclear if it is of the same entity as major depressive disorder (MDD). The study focuses on possible gender differences in IFN-α induced depression and effects of a pre-emptive antidepressant treatment. Methods Data from 181 patients with chronic hepatitis C infection (cHC) without history of mental illnesses undergoing treatment with IFN-α 2a and ribavirin were re-analyzed for gender effects. Patients with a pre-emptive antidepressant therapy with Escitalopram (n = 90, verum group) to prevent IFN-induced depression were compared to patients who r…

medicine.medical_specialtyHamilton Anxiety Rating Scalebusiness.industryAlpha interferonmedicine.diseasePlacebo030227 psychiatry03 medical and health sciencesPsychiatry and Mental healthClinical Psychology0302 clinical medicineRating scaleInternal medicinemedicineMajor depressive disorderAntidepressantEscitaloprambusiness030217 neurology & neurosurgeryDepression (differential diagnoses)medicine.drugJournal of Affective Disorders
researchProduct

Pharmacological interventions for people with narcissistic personality disorder

2011

Reason for withdrawal from publication Authors have made no progress with this protocol in over two years due to difficulties with identifying potentially suitable studies. The protocol has been withdrawn. To view the published versions of this article, please click the 'Other versions' tab.

Protocol (science)Pharmacological interventionsPsychotherapistbusiness.industryNarcissistic personality disorderMedicinebusinessmedicine.disease
researchProduct

Pharmacological Neuroenhancement: Substances and Epidemiology

2013

Pharmacological neuroenhancement (PN) refers to the general use of psychoactive substances with the purpose of cognitive enhancement (e.g. enhancement of vigilance, concentration, memory or mood) by healthy subjects. Substances for PN include Over-the-Counter- (OTC-) substances such as coffee, caffeinated drinks/energy drinks, caffeine tablets and Ginkgo biloba as well as prescription drugs and illicit drugs (e.g. (psycho-) stimulants). “Brain doping” refers to the illicit use of a subcategory of these substances. On the one hand, this subcategory includes prescription drugs for the treatment of attention deficit/hyperactivity disorder (ADHD), sleep disorders, Alzheimer’s disease and depres…

Methylphenidatebusiness.industryEcstasyModafinilMemantineNeuroenhancementPharmacologychemistry.chemical_compoundMoodchemistrymental disordersmedicineMedical prescriptionCaffeinebusinessmedicine.drug
researchProduct

Women with borderline personality disorder do not show altered BOLD responses during response inhibition.

2015

Impulsivity is central to borderline personality disorder (BPD). Response inhibition, addressing the ability to suppress or stop actions, is one aspect of behavioral impulse control which is frequently used to assess impulsivity. BPD patients display deficits in response inhibition under stress condition or negative emotions. We assessed whether response inhibition and its neural underpinnings are impaired in BPD when tested in an emotionally neutral setting and when co-morbid attention-deficit/hyperactivity disorder (ADHD) is excluded. To this end, we studied response inhibition in unmedicated BPD patients and healthy controls (HC) in two independent samples using functional magnetic reson…

Adultmedicine.medical_specialtyEmotionsNeuroscience (miscellaneous)AudiologyNeuropsychological TestsImpulsivitybehavioral disciplines and activitiesDevelopmental psychologyYoung AdultBorderline Personality Disordermental disordersmedicineControl networkReaction TimeHumansRadiology Nuclear Medicine and imagingYoung adultBorderline personality disorderResponse inhibitionIntelligence TestsIntelligence quotientmedicine.diagnostic_testMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingDisruptive Impulse Control and Conduct DisordersPsychiatry and Mental healthInhibition PsychologicalAttention Deficit Disorder with HyperactivityImpulsive BehaviorFemalemedicine.symptomPsychologyFunctional magnetic resonance imagingPsychomotor PerformancePsychiatry research
researchProduct

Assessment of Microstressors in Adults: Questionnaire Development and Ecological Validation of the Mainz Inventory of Microstressors

2020

Background Many existing scales for microstressor assessment do not differentiate between objective (ie, observable) stressor events and stressful cognitions or concerns. They often mix items assessing objective stressor events with items measuring other aspects of stress, such as perceived stressor severity, the evoked stress reaction, or further consequences on health, which may result in spurious associations in studies that include other questionnaires that measure such constructs. Most scales were developed several decades ago; therefore, modern life stressors may not be represented. Ecological momentary assessment (EMA) allows for sampling of current behaviors and experiences in real…

validationOriginal PaperEcologyEcological validity05 social sciencesStressorMultilevel modelecological momentary assessmentCognitionmicrostressordaily hassles050105 experimental psychologyModern life03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineRecall bias0501 psychology and cognitive sciencesdaily hassles ; microstressor ; ecological momentary assessment ; validationPsychologyAssociation (psychology)030217 neurology & neurosurgeryJMIR Mental Health
researchProduct

Effectiveness of Antipsychotic Medication in the Treatment of BPD

2017

IntroductionThough prescription is off-lable, “atypical” or “second-generation” antipsychotics (SGAs) are prevalently given to borderline personality disorder (BPD) patients. They have also been the focus of research on pharmacological agents in BPD in recent years, as the previous version of the relating cochrane systematic review shows.ObjectivesWe are currently updating this cochrane systematic review on pharmacological interventions for BPD. First findings on the up-to-date evidence relating to SGAs will be presented.MethodsWe conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) according to cochrane collaboration standards. Any randomized comparisons o…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentmedicine.diseasePlaceboPersonality disorderslaw.inventionPsychiatry and Mental healthRandomized controlled trialTolerabilitylawmedicineAnxietymedicine.symptomMedical prescriptionPsychiatryAntipsychoticbusinessBorderline personality disorderClinical psychologyEuropean Psychiatry
researchProduct

Psychological interventions to foster resilience in healthcare students

2020

Background Resilience can be defined as maintaining or regaining mental health during or after significant adversities such as a potentially traumatising event, challenging life circumstances, a critical life transition or physical illness. Healthcare students, such as medical, nursing, psychology and social work students, are exposed to various study- and work-related stressors, the latter particularly during later phases of health professional education. They are at increased risk of developing symptoms of burnout or mental disorders. This population may benefit from resilience-promoting training programmes. Objectives To assess the effects of interventions to foster resilience in healthc…

AdultMaleStudents Health OccupationsWaiting Listsmedia_common.quotation_subjectPopulationPsychological interventionAllied Health PersonnelAnxiety03 medical and health sciencesYoung Adult0302 clinical medicineQuality of life (healthcare)BiasHealth careMedicineHumansPharmacology (medical)030212 general & internal medicineeducationmedia_commonRandomized Controlled Trials as Topiceducation.field_of_studybusiness.industryAllied Health OccupationsDepressionResilience PsychologicalAllied health professionsMental healthMental HealthMeta-analysisQuality of LifeFemalePsychological resiliencebusiness030217 neurology & neurosurgeryStress PsychologicalClinical psychology
researchProduct

Intervention studies to foster resilience – A systematic review and proposal for a resilience framework in future intervention studies

2017

Psychological resilience refers to the phenomenon that many people are able to adapt to the challenges of life and maintain mental health despite exposure to adversity. This has stimulated research on training programs to foster psychological resilience. We evaluated concepts, methods and designs of 43 randomized controlled trials published between 1979 and 2014 which assessed the efficacy of such training programs and propose standards for future intervention research based on recent developments in the field. We found that concepts, methods and designs in current resilience intervention studies are of limited use to properly assess efficacy of interventions to foster resilience. Major pro…

media_common.quotation_subjectApplied psychologyPsychological interventionlaw.inventionAssessment ; Intervention ; Training ; Randomized controlled trial ; Resilience ; Stress03 medical and health sciences0302 clinical medicineRandomized controlled triallawIntervention (counseling)Adaptation PsychologicalHumans030212 general & internal medicineRandomized Controlled Trials as Topicmedia_commonClinical study designStressorResilience PsychologicalMental healthPsychiatry and Mental healthClinical PsychologyMental HealthFoster carePsychological resiliencePsychologyStress Psychological030217 neurology & neurosurgeryClinical psychologyClinical Psychology Review
researchProduct